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ABSTRACT

Different aspects of DNA affinity chromatography such as DNA complexity
heparin elution, the Bi-column method and the oligonucluotide trapping method
were studied. The complexity (length) of a DNA sequence attached to an affinity
chromatography column affects column retention, and the purity of transcription
factors obtained. T18: A18 tailed DNA affinity columns were better suited for
purification of most of the transcription factors than either the discrete or
concatemeric DNA affinity columns. A novel method using heparin for eluting
transcription factors from DNA Sepharose columns was characterized. The
amount of the lac repressor chimera which eluted from the column was shown to
increase with increases in the mobile phase heparin concentration. The elution of
the protein was also shown to be dependent on the amount of DNA coupled to
the column and more protein eluted from columns containing lesser amounts of
DNA. These data suggest that heparin and DNA compete for binding to the
protein; this competition causes elution. Comparison of heparin- and salt-eluted
protein demonstrated the heparin-eluted fraction of lac repressor was
significantly purer than that eluted with salt and comparable to that obtained by
elution with the specific ligand IPTG, a lactose analog. A novel Bi-column method
was developed in which lac repressor is eluted from the Op1-Sepharose with a
low heparin concentration and trapped on a Op1T18-Sepharose column because
of its higher affinity for the lac repressor protein. Elution of the latter column with
buffer containing a high salt concentration gives significantly purer transcription
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factor than the conventionally used single column methods and removes residual
heparin. Highly pure CAAT enhancer binding protein(C/EBP) and the B3
transcription factor are also obtained by using variants of this Bi-column method.
A new oligonucleotide trapping method in which a short oligonucleotide coupled
to Sepharose is used to trap a complex of the transcription factor and its
corresponding specific DNA sequence was developed. Highly purified
transcription factor B3 was obtained using the oligonucleotide trapping method.
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Chapter: 1. Transcription factor purification: A brief
overview

Part of this chapter was published in Analytical Biochemistry (2001) 290:
147-78. Permission was obtained from the publisher to use our published article
in the dissertation. Some variations in format were adapted for the dissertation.
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1.1. Introduction
DNA binding proteins control cellular processes such as DNA replication,
repair, and recombination, which allow an organism’s development,
embryogenesis, etc. Transcription factors belong to the larger family of DNA
binding proteins and control gene expression. Timely regulation of genes is
important in all living organisms. In higher eukaryotes regulation of genes is
responsible for proper functioning of the cell cycle, proper control of metabolic
pathways, and the ultimate type of cell produced at differentiation. Genetic
regulation in prokaryotes is required for proper response to environmental
conditions and their ultimate survival. Cellular and viral encoded transcription
factors are also important for viral propagation. Transcription factors control gene
expression by binding to specific DNA elements in the promoter region. In
mammals transcription factors such as AP-1, cMyc, E2F, etc. are important
regulators of cell cycle (1) (2) (3). In bacteria such as Escherichia coli, lac
repressor protein controls the expression of the lactose operon genes in
response to the presence of lactose in the medium (4) (5). In viruses such as
bacteriophage λ, the counteractive effect of the transcription factors Cro and λ
repressor determines whether the phage enters the lytic or the lysogenic phase
(6). Improper functioning of transcription factors in humans contributes to
diseases such as cancer, dwarfism and congenital severe combined
immunodeficiency (7).
Purification of transcription factors from tissue extracts is challenging, as
they are normally present at very low concentration. This problem is further
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compounded by the fact that several purification steps are needed for the
complete purification of a particular transcription factor and some amount of the
transcription factor is lost at each step. In this chapter we will briefly discuss the
classification, assay, and purification of transcription factors. The major focus of
the chapter will be on sequence specific DNA affinity chromatography.

1.1.1 Brief overview of transcription factors
A detailed discussion of transcription factor structure, function and
regulation is beyond the scope of this chapter, but are the subject of several
books and review articles (8) (7) (9) (10) (11) (12). Transcription factors regulate
gene expression by binding to a specific region of DNA, which is normally located
upstream (5’) of the gene in the promoter region. A classic example of a
transcription factor is the lac repressor protein which, upon binding to its operator
element (Op1), represses the expression of lac operon genes (13). Transcription
factors can either repress the expression of the gene, as is the case for lac
repressor or it can enhance gene expression. A good example of the latter is the
CAAT enhancer binding protein (C/EBP) which binds specifically to DNA
sequences containing a CAAT element. C/EBP participates in the regulation of
expression of several genes in higher eukaryotes. The promoter region in both
eukaryotes and prokaryotes usually contains multiple elements and binds more
than one transcription factor. Thus, genetic regulation of a particular gene is the
result of the interplay between multiple transcription factors and, ultimately, an
RNA polymerase.
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Transcription factors usually consist of two distinct domains, the activation
domain and the DNA binding domain. The activation domain functions by
recruiting components of the basal transcription complex such as RNA
polymerase, factors associated with RNA polymerase, or other transcription
factors at the promoter region. Activation domains may bind these proteins
directly or may interact indirectly through a coactivator protein. Activation
domains have been classified based upon their distinct amino acid content such
as a predominance of acidic amino acids, proline and glutamine residues, etc.
(9).
The DNA binding domain is responsible for binding to the specific DNA
element, which to a greater or lesser degree, matches an ideal sequence called
the consensus sequence. Each transcription factor usually recognizes only a
specific consensus sequence and the consensus sequences vary from one
transcription factor to another. For example, transcription factors belonging to the
C/EBP family bind specifically to sequences containing the CAAT element while
members of the Sp1 family bind to the GC box element, which has a high GC
content. The specific interaction between transcription factor and the consensus
DNA sequence is of a great biological importance as it allows a transcription
factor to regulate expression of a certain set of genes whose promoter contains
the specific response element while the expression of other genes remains
unaffected. The match of the response element to the consensus sequence
determines how strongly the corresponding transcription factor binds and,
presumably, how large an effect it has on gene expression.
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1.1.2 Transcription factor motifs
The distinct structural motifs present in the DNA binding domain are
responsible for the binding specificity of the transcription factors. Transcription
factors are frequently classified according to these structural features. These
classes of transcription factors are briefly discussed below; for detail reviews
refer to (14) (15).
1.1.2.1 Helix turn helix (HTH) family
Helix turn helix (HTH) was the first DNA binding motif to be recognized.
Transcription factors belonging to this family include the lac repressor protein, the
λ repressor and the trp repressor protein (15). Homeodomain proteins, which
play an important role in development of higher organisms also, belong to this
family (16) (17). The HTH motif consists of two α helices joined together by a
short stretch of amino acids, which forms the turn (18). Proteins belonging to this
family usually bind to the DNA as a dimer wherein each monomeric subunit
recognize a half site in the DNA. There are, of course, exceptions such as lac
repressor, which binds as a tetramer (13).
1.1.2.2 Zinc finger proteins
The first zinc finger motif was identified in the Xenopus transcription factor
III (TFIIIA). Since then several transcription factors have been shown to contain
this motif, e.g., Sp1, steroid and thyroid receptors, zif268 and many others. The
TFIIIA zinc finger motifs contains the sequence pattern:
Cys-X2 or 4-Cys-X12-His-X3-5-His (15).
Although the sequence varies in the different zinc finger proteins, the common
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feature is the presence of either four histidines or two histidines and two
cysteines. The cysteines and histidines tetrahedrally coordinate a zinc atom while
remaining amino acids form a finger like protrusion responsible for DNA
recognition; hence, the name zinc finger motif. Many of the proteins belonging to
this family contain several zinc finger motifs arranged in tandem arrays wherein
the α helical structures in the fingers can make continuous contact with the major
groove of DNA. For example, TFIIIA has 9 zinc finger motifs responsible for its
binding to DNA and also RNA.
1.1.2.3 The leucine zipper motif
The leucine zipper motif consists of two regions, the leucine zipper region,
which contains heptad repeats of leucine and a basic region, which contains
predominantly basic amino acids. Several transcription factors are known to have
this motif; the most prominent are C/EBP, Ig/EBP, CREB, c-fos, and c-jun (15).
The leucine zipper region has 30-40 residues, which are arranged in the form of
an α helix (with 3.6 amino acids per turn) such that the leucine residues
(occurring every seven residues) are arranged on the same face of the helix.
This specific arrangement of leucines brings about dimerization between two
monomers as the interstrand leucines intercalate and form tight contacts with
each other. The arrangement of the leucines on the two strands is like that of the
teeth on a zipper. Dimerization results in a “Y” shaped structure in which leucine
zipper regions of the two monomers are joined to form the stem while the basic
regions remain separate to form the fork. The basic regions form strong
electrostatic interactions with the negatively charged DNA phosphate backbone
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(19).
1.1.2.4 Helix loop helix (HLH)
Like the leucine zipper proteins, HLH proteins are also comprised of two
distinct regions, a basic region that is involved in binding to the DNA and a
adjacent region that is involved in dimerization (20). Myo D protein, which is
involved in muscle differentiation, belongs to this family.
1.1.2.5 Other motifs
Although many of the transcription factors can be assigned to one of the
families mentioned above, there are other DNA binding motifs which have been
identified but have been found less commonly. The most predominant among
these is the β sheet motif. Proteins containing this motif use the antiparallel β
sheets to bind to the DNA. Other motifs include the “Zinc cluster” motif found in
Gal4, the LIM motif found in some of the homeodomain proteins, and the POU
domain present in POU proteins (15).

1.1.3 Assay of transcription factors
Many families of transcription factors such as Sp1, C/EBP, and AP-1 have
been identified and well characterized (21) (22) (23). There are other members to
these families such as Sp1, Sp2, Sp3, and Sp4 that are similar but distinct
proteins. There are also many other transcription factors which have not been
fully characterized and others about which virtually nothing is known. The first
step in the characterization of a transcription factor is to purify it sufficiently so
that it can be sequenced and cloned.
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A highly sensitive and specific assay is prerequisite for the purification of
any protein. Hence, it is important to have good detection methods for identifying
transcription factors. Transcription factors usually bind their cognate DNA
sequence with affinities in the picomolar range and have a 103-105 higher affinity
for this specific DNA sequence than for any other DNA sequences. This high
binding affinity has been utilized for the assay of transcription factors in the
different techniques described below.
1.1.3.1 Filter binding assay
The filter binding assay is one of the most popular assays for detecting
transcription factors because of its ease of operation. It was first used for
detection of the lac repressor protein (24). Since then, the filter binding assay has
been widely used to detect and to analyze the thermodynamics and kinetics of
DNA-protein interactions (25) (26) (27). Nitrocellulose membranes bind
specifically to proteins without interacting with DNA. This property of
nitrocellulose membrane forms the basis of filter binding assay. Transcription
factor fractions are mixed with radiolabeled DNA containing the specific DNA
element. The mixture is then filtered and, because of the protein binding, the
transcription factor-DNA complex is retained on the filter. After thorough washing,
the radiolabel remaining on the filter allows quantitation of the complex. For
further details, see (25). The advantages of this technique are the ease and
rapidity of analysis. The major disadvantage is the low specificity. In crude
fractions, most of the protein bound by the filter is not the transcription factor of
interest and competes with it for filter binding. Thus, filter binding assays are
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seldom applied to crude extracts.
1.1.3.2 Electrophoretic mobility shift assay (EMSA)
Like the filter binding assay, the electrophoretic mobility shift assay
(EMSA) also utilizes radiolabeled specific oligonucleotide to detect transcription
factors. In this assay a radiolabeled oligonucleotide is incubated with a
transcription factor containing fraction. A non-labeled competitor DNA such as
poly(dI:dC) is added to lessen non specific binding. This mixture is then
subjected to nondenaturing polyacrylamide gel electrophoresis (PAGE). When
the transcription factor present in the extract binds to the probe it retards the
mobility of the probe (shifts it) on PAGE which can be easily detected after
autoradiography (28). When an antibody against a transcription factor is
available, a super shift assay can be performed. In this method EMSA is carried
out in presence of the antibody and an even greater retardation in the mobility is
observed because of formation of DNA-transcription factor-antibody complex.
Sometimes biotin- or digoxygenin-labeled probes are utilized in EMSA to provide
an alternative which uses no radiolabel (29) (30). Techniques similar to EMSA
which involve separation of the DNA-transcription factor complex by high
resolution gel filtration have also been used (31). Modifications of EMSA, such as
affinity coelectrophoresis (ACE), have been developed to measure DNA binding
constants (32). The major advantages of EMSA are high specificity and ease of
operation.
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1.1.3.3 Capillary electrophoresis mobility shift assay (CEMSA)
CEMSA is a modification of EMSA in which instead of resolving DNAprotein complex on a gel it is resolved on the basis of charge to mass ratio with
small uncoated capillaries (33). CEMSA is very rapid and can be used for precise
determination of binding constants of DNA-protein interaction. It is also highly
sensitive as it uses laser-induced fluorescence to detect fluorescein labeled
oligonucleotides. Because of these advantages CEMSA is gaining in popularity
(33) (34). The main disadvantages are the cost of the equipment and the
sensitivity of most electrophoresis, and especially capillary electrophoresis, to
salt concentrations.
1.1.3.4 Protection assay (DNA footprinting)
In footprinting experiments the ability of transcription factors to protect
bound DNA from enzymes such as nuclease or methylase, or from chemical
treatments is assayed. Upon binding to DNA a transcription factor shields it from
the above mentioned modifications. The region of DNA that is protected (the
“footprint”) is often the minimal sequence required for DNA-transcription factor
interaction. In DNAse1 protection assay, the first step is to radiolabel specifically
only one strand. This DNA and the DNA-transcription factor complex is then
treated with DNAse1, an endonuclease, which randomly cleaves the chain
preferentially at pyrimidines. The area where the transcription factor is bound is
protected from cleavage. By analyzing the reaction products on a DNA
sequencing gel, next to one or more DNA sequencing reactions (to provide
length and sequence markers), a region is found where no cleavages occurred in
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the presence of transcription factor. This region is usually called the transcription
factor's “footprint”. The reaction is repeated radiolabeling the other strand to
confirm location and to determine the boundaries of the footprint on each strand.
The DNAse I footprinting method is highly specific and hence is often used
in assaying transcription factors despite being technically more difficult than
either EMSA or filter binding assay. Other methods of footprinting involve the use
of small molecules such as the hydroxy radicals or even γ rays to cleave the
unbound DNA (35) (36). Principally these methods are similar to DNAse1
footprinting except for the agent used to cleave DNA. The major advantage of
using these agents is that better resolution can be obtained because of their very
small size.
Other sophisticated methods such as fluorescence anisotropy and surface
plasmon resonance spectroscopy have been used to detect DNA-protein
interaction (37) (38). These methods require expensive instrumentation and more
complex operation and hence are not yet routinely used to assay transcription
factors.

1.2. Purification of transcription factors
The number of transcription factors that have been purified to
homogeneity is growing continuously. Table 1.1 shows the different transcription
factors that have been purified in the last 8 years. A survey of the purification of
transcription factor homology families show that they are all purified in basically
similar ways. There is no technique that stands out as being especially applicable
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Table 1.1. List of transcription factors purified in the last few years.

Transcription

Source

factor

Protein

Steps used to

Additional

Refe-

sequence

accomplish purification

strategies and

rence

components used

obtained
-Heparin-agarose

-Concatemeric

nuclear

-Phosphocellulose

sequences

extract

-Ion exchange

Transcription

HeLa

factor III C

Yes

(39)

chromatography
-DNA cellulose
-Sequence-specific
DNA affinity column
SpE2F

H2TF1

Schizosac

-Heparin-agarose

-Concatemeric

charomyc

-Sequence-specific

sequences

es pombe

DNA affinity column

HeLa cells

No

Yes

-Ion exchange

-Both monomeric

chromatography

and concatemeric

-Heparin-agarose

DNA affinity

-Sequence-specific

columns were

DNA affinity column

effective for

(40)

(41)

purification
PCF

HepG2

Yes

-Heparin-agarose

-Concatemeric

nuclear

-Sequence-specific

sequences

extract

DNA affinity column

12

(42)

Table 1.1 continued
Transcription

Source

factor

Protein

Steps used to

Additional

Refe-

sequence

accomplish purification

strategies and

rence

components used

obtained
TFIIIA

HeLa cells

Yes

-Biorex70

-Monomeric DNA

-Sequence-specific

sequences.

(43)

DNA affinity column
NF-AT

Jurkart

Yes

-Ion exchange

-Concatemeric

cell

chromatography

DNA sequences

nuclear

-Heparin-Sepharose

-Mutated DNA

extract

-Octylamine agarose

affinity column.

(44)

-Sequence-specific
DNA affinity column

TPBF

TFIIIC

Acantham

-Ion exchange

-Concatemeric

oeba

chromatography

DNA sequences

nuclear

-Sequence-specific

extract

DNA affinity column

Discothelli

Yes

No

um

-Ion exchange

-Concatemeric

chromatography

DNA sequences

(45)

(46)

Discoidum
.

-Sequence-specific
DNA affinity column

GRIP170

HeLa S3

Yes

-Ion exchange

nuclear

chromatography

extract.

-Heparin Sepharose

13

(47)

Table 1.1 continued
Transcription

Source

factor

Protein

Steps used to

Additional

Refe-

sequence

accomplish purification

strategies and

rence

components used

obtained
MtEBPs

-Ion exchange

-Monomeric DNA

n nuclear

chromatography

sequences

extract

-Heparin-Sepharose

Mammalia

No

(48)

-Sequence-specific
DNA affinity column

Stat3

Rat liver

Yes

-Ion exchange

-Concatemeric

nuclear

chromatography

DNA sequences

extract

-Phenyl-Sepharose

(49)

-Sequence-specific
DNA affinity column
NF1-L

AF-1

Rat liver

-Heparin-Sepharose

-Concatemeric

nuclear

-Calf thymus DNA

DNA sequences

extract

affinity

- Repetitive use

-Sequence-specific

of DNA affinity

DNA affinity column

chromatography

MLA144

Yes

Yes

-Phenyl-Sepharose

cells

-Bio-Rex70

nuclear

-Superose 6 gel

extract

filtration

14

(50)

(51)

Table 1.1 continued
Transcription

Source

factor

Protein

Steps used to

Additional

Refe-

sequence

accomplish purification

strategies and

rence

components used

obtained
UEF3

HeLa cell

No

extract

-Ioexchange

-Concatemeric

chromatography

DNA sequences

-heparin Sepharose

-Mutant DNA

-Sequence-specific

affinity.

(52)

DNA affinity column
Inr-BP

NF-Y

Bovine

-Heparin agarose

-Monomeric DNA

testis

-All-gel blue

sequences

nuclear

-Sequence-specific

extract

DNA affinity column

YNIH3T3

No

Yes

cell

SEF

-Concatemeric

DNA affinity column

DNA sequences

nuclear

-Magnetic bead

extract

purification

HeLa cell

Yes

-Ion exchange

-Concatemeric

-Phenyl-Sepharose

DNA sequences

-Sequence-specific

-Magnetic bead

DNA affinity column

separation

-Heparin agarose

-Concatemeric

nuclear

-Wheat germ lectin

DNA sequences

extract

-Sequence-specific

extract

TEF1

-Sequence-specific

Rat kidney

No

DNA affinity column

15

(53)

(54)

(57)

(58)

Table 1.1 continued
Transcription

Source

factor

Protein

Steps used to

Additional

Refe-

sequence

accomplish purification

strategies and

rence

components used

obtained
Recombinant

Crude

C/EBP

bacterial

Yes

-Sequence-specific

-Monomeric DNA

DNA affinity column

sequences

(59)

-Temperature

extract

dependant
elution of C/EBP
Reconbinant

Yes

lac repressor

-Sequence-specific

-Monomeric DNA

DNA affinity column

sequences

(60)

-Heparin elution
of lac repressor
B3

Xenopus

Yes

oocyte

-Sequence-specific

-Monomeric DNA

DNA affinity column

sequences

extract

(61)

-Bi-column
method

C/EBP

Rat liver
nuclear

Yes

-Sequence-specific

-Monomeric DNA

DNA affinity column

sequences

extract

-Bi-column
method

16

(61)

to any one family of proteins. The DNA affinity chromatography is also basically
the same. As mentioned before, purification of a transcription factor is an early
step in its characterization.
Purification of transcription factors starts with identifying a suitable assay
system, which has been discussed in section 1.2.1 of this chapter, and obtaining
the DNA footprint sequence. The next step is to choose an appropriate tissue in
the case of eukaryotic systems, and appropriate growth conditions in the case of
prokaryotic systems. For example, C/EBP-α is more abundant in liver and hence
rat liver nuclear extracts are often used in its purification (62). In eukaryotes
transcription factors are predominantly present in the nucleus and hence nuclear
extracts are often used, instead of whole cell extracts, for their purification. Use
of nuclear extracts leads to10-100 fold enrichment of transcription factors and
other DNA binding proteins. In the case of bacterial systems whole cell lysate is
usually the starting material. In these systems it is important to identify growth
conditions which give maximum expression of transcription factor of interest.
At least 4-5 different chromatographic steps are often required for the
purification of transcription factors from such extracts. These steps include use of
ion exchange, reversed phase (hydrophobic interaction chromatography), gel
filtration, nonspecific and sequence specific DNA affinity columns (see columns 4
and 5, Table 1.1).
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1.2.1 Non-affinity techniques
Ion exchange columns such as Mono S and Mono Q, DEAE cellulose,
phosphocellulose or heparin-agarose are routinely used as a preliminary step in
the purification of transcription factors. Heparin-agarose is anionic but is thought
to function in a unique manner. The polyanionic sugar backbone of heparin is
thought to form a structure that resembles the negatively charged DNA
phosphate sugar backbone and hence is bound by most of the DNA binding
proteins (and other proteins too). For this reason heparin-agarose is used almost
ubiquitously in purification of transcription factors and other DNA binding
proteins. Examples of gel filtration include the Sephacryl S300 used in purifying
Sp1 (21) and reverse phase columns include the Aquapore butyl HPLC columns
used for purification of C/EBP (62). Of all the methods mentioned above, DNA
affinity chromatography has the highest selectivity and specificity and is often the
most important step in purifications involving transcription factors and hence will
be the major focus of the rest of this chapter.

1.2.2 DNA affinity chromatography
DNA affinity columns are made by coupling nonspecific or specific DNA to
supports such as cellulose or Sepharose. Non specific DNA-cellulose columns
were among the first DNA affinity columns used for purification of DNA binding
proteins. Non specific columns are made from Salmon or herring sperm DNA.
Nonspecific columns are not selective for a particular protein as almost all DNA
binding proteins are able to bind to these columns. None-the-less, nonspecific
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DNA-cellulose columns are commonly used as one of the many steps in
purification of transcription factors (63) (64) (65) (66). Specific DNA affinity
columns on the other hand are tailor made for a particular transcription factor of
interest by coupling of the DNA footprint region (see section 1.2.1.4 for details on
footprinting). The transcription factor of interest binds to its footprint region with a
high affinity while most of the other DNA binding proteins have only a moderate
affinity for this region and can be washed off from the columns with appropriate
salt concentrations. Different aspects of DNA affinity chromatography such as the
supports used and elution methods are discussed in the following sections.
1.2.2.1 The stationary phase
Many supports such as cellulose, Sepharose, latex and silica have been
use to make DNA affinity columns. An ideal support is one that is inert and does
not bind nonspecifically to proteins. Other desirable properties in a support are
that it should be resistant to pressure and shearing, should be spherical and
uniform, and should have a high mass transfer rate. No support reaches this
ideal but some are quite good.
1.2.2.1.1 Cellulose
DNA cellulose was one of the first DNA affinity supports to be used in the
purification of transcription factors (67). The major deficiencies of cellulose are
that several proteins are able to bind to cellulose nonspecifically, it is made of
irregular fiber lengths which do not pack uniformly in a column, it swells and
shrinks in response to hydrostatic or osmotic pressures, and it is restricted to low
pressure. While cellulose is still used, it has been superceded by better supports.
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1.2.2.1.2 Sepharose
Sepharose is by far the most widely used support for making sequence
specific DNA affinity columns (60) (21) (68). The major advantage of Sepharose
is that it shows low nonspecific binding to proteins, has a wide range of coupling
chemistries available for it, and is relatively cheap. The major disadvantages are
that it is not resistant to high pressure and hence cannot be used in HPLC, and,
like most soft gels, it shrinks and swells in response to osmotic and hydrostatic
pressure, and has slow mass transfer.
1.2.2.1.3 Silica
In many ways silica is a nearly ideal support. It is mechanically rigid and
does not shrink or swell in response to pressures, is available in precisely sized
spheres of uniform porosity, and is available in a large number of surface
coatings. Silicas have some of the highest mass transfer rates of any support,
easily surpassing the soft gels. It is unstable at pH values less than about 3 or
greater than about 7.5, but this has a larger effect on the availability of coupling
methods than upon its chromatographic performance. DNA-silica is not widely
used primarily because it was developed only about ten years ago (69) and the
techniques of column packing and coupling chemistry are not widely known.
1.2.2.1.4 Latex beads
Latex beads are made of a styrene core and a glycidyl methacrylate
(GMA) surface (70) (71). Latex beads are small in size and show high capacity
for the DNA and moderately high mass transfer rates. Latex beads also show low
nonspecific binding and are thought be a nearly ideal low pressure DNA affinity
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support. As with silica though, this support has become available later than the
soft gels and cellulose and is not widely used because of investigator
unfamiliarity with the techniques involved.
1.2.2.2 Coupling chemistries
DNA can be coupled to the above-mentioned supports by either covalent
or noncovalent means. Coupling chemistries for covalent attachment of DNA
have been described for reaction occurring through the DNA bases and from
endpoint attachment of DNA molecules to the support. The most widely used
method for coupling DNA is to CNBr activated Sepharose (21) (60). In the
methods where the end point attachment is not used, the inherent functional
groups of nucleotide bases (e.g., the amino groups of A, C, and G or hydroxyl
groups on the sugar phosphate backbone) are chemically coupled to the matrix.
The major disadvantage in coupling of inherent groups is that such
reaction can modify DNA structure and affect the performance of the affinity
columns. When end point attachment is used the major interaction is thought to
take place between groups placed at the 5’ or 3’ end of DNA and the matrix.
Therefore the end point attachment is preferred over the former method. But
even with the end point attachment method some modification of DNA
nucleotides does take place and could affect the performance of the column. In
noncovalent coupling procedures the DNA sequence to be coupled is never
exposed to any chemical modification and hence, may sometimes function
better. The most commonly used noncovalent attachment method is
immobilization of biotin labeled DNA onto streptavidin-coated supports (72) (73).
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Other methods such as enzymatic synthesis (74) (75) are also available and
have been discussed in details elsewhere (76).
1.2.2.3 Nature of DNA used for making sequence specific columns
The footprint region represents the minimum region of DNA required for
interaction with its corresponding transcription factor. Ideally, the footprint region
is the shortest sequence that can be used for making sequence specific DNA
affinity columns. There are studies, which imply the use of longer DNA
sequences, such as from plasmids, containing the footprint region, or
concatemeric repeats of the footprint region, may function better than simple,
discrete short footprints (77) (78). There is however a complete lack of
comparative data to support such claims. None-the-less, the concatemeric
method has been widely used and often successfully (see Table 1.1). The
disadvantage of using longer sequences is that a longer sequence would contain
additional DNA sequences, potentially bound by other proteins. For example, if a
plasmid harboring the footprint region is used, only a small portion of the plasmid
would represent the specific sequence and the rest of it would be nonspecific
sequence which could be bound by other DNA binding proteins in the crude
extract and hence decrease the selectivity of the column. Concatemerization on
the other hand introduces new sequences which are absent in the original
footprint region and again could decrease the selectivity of the column.
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1.2.2.4 Elution of proteins from DNA affinity columns
1.2.2.4.1 Salt elution
When transcription factors bind DNA, they displace Na+ and other counterions from the DNA (79). Thus, high Na+ concentrations diminish DNA-protein
binding. But this displacement is common to all transcription factors and thus the
salt gradient is unlikely to be very selective. Salt elution is the most common
method for eluting proteins from DNA affinity columns. A step gradient or a linear
gradient with increasing salt concentration is normally employed for salt elution;
NaCl and KCl are the most common salts used. Salt elution is indiscriminate and
most of the proteins bound to the column are eluted with salt. Linear salt
gradients may separate some of these proteins. Proteins that bind nonspecifically
to the DNA may have a lower affinity for it and would presumably elute at low salt
concentrations. The protein of interest should have the highest affinity for the
coupled DNA and elute later in the gradient. But in practice salt elution has only
moderate resolution and absolute separation is only rarely obtained with salt
elution.
1.2.2.4.2 Ligand specific elution
Certain transcription factors lose their DNA binding activity when bound to
specific ligands. For example, the lac repressor protein is unable to bind to DNA
when it is bound by ligands such as IPTG or lactose. Such transcription factors
can be eluted from DNA affinity columns by using specific ligands. Since ligands
will elute only one specific protein from columns, ligand elution is highly selective
and can yield highly purified protein. The major drawback of this method is that
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only a small number of transcription factors are known to respond to ligands and
hence ligand elution cannot be widely use. There are a very few examples of
ligand specific elution in literature (72) (60).
1.2.2.5 Use of nonspecific (competitor) DNA in the mobile phase
The EMSA can be made specific for a particular transcription factor by
using a nonspecific DNA sequence as a competitor to eliminate binding of
extraneous DNA binding proteins. Similarly, competitor DNA can be added to the
mobile phase used in DNA affinity chromatography to minimize nonspecific
proteins binding to the DNA affinity column, as first proposed by Alberts and
Herrick (80). Nonspecific competitor DNA has often been used in DNA affinity
chromatography (see Table 1.1) to increase the purity but a systematic study on
the use of competitor DNA has not been reported. It has been suggested that the
highest concentration of competitor DNA that causes no inhibition in EMSA
should be used as a reference and 5 times lower concentration than the
reference concentrations should be used in mobile phase (78). While this
provides a standard approach to choosing a competitor concentration, the
concentration of specific oligonucleotide used in EMSA are low and in the range
of 0.2-0.5 µM but the concentrations of DNA in affinity columns are often two
orders of magnitude higher and EMSA-derived competitor concentrations may
bear little on column chromatography. None-the-less, competitor DNA is widely
used in DNA affinity chromatography and probably does increase the purity to a
certain extent.
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1.3. Conclusions
Sequence specific DNA affinity columns probably have greatest selectivity
of all the methods available for purification of transcription factors. However
homogenous transcription factor in only rarely obtained by using DNA affinity
chromatography as the only step. Improvements in the technique such as
optimization of DNA sequence used for making sequence specific DNA affinity
columns, developing new methods for eluting transcription factors from these
columns would help to increase the purification efficiency of DNA affinity
columns.
Studies on the DNA length optimization, heparin elution and new
purification techniques such as the bi-column and oligonucleotide trapping
methods will be discussed in the subsequent chapters.
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Chapter: 2. Comparative studies on chemically and
enzymatically coupled DNA-Sepharose columns for purification
of a lac repressor chimeric fusion protein

.

Part of this chapter was published in Journal of Chromatography (1999)

849: 403-12. Permission was obtained from the publisher to use our published
article in the dissertation. Some variations in format were adapted for the
dissertation.
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2.1. Introduction
DNA affinity chromatography is frequently an important step in the
purification of transcription factors and other DNA binding proteins. DNA affinity
chromatography offers greater selectivity and hence is preferred over other
methods. Affinity chromatography involves coupling of a DNA sequence to a
solid support such as Sepharose, cellulose or silica. The different methods of
coupling have been reviewed previously (78) (76).
Our lab developed protocols for template-directed enzymatic synthesis of
DNA columns using DNA polymerase or reverse transcriptase (81) (82) (83).
This procedure involves coupling of the 5' end of oligomeric (T)18 to a solid
support, using chemistry which does not result in the modification of thymidine
bases. A template sequence containing a 3’-oligoadenylate tail is then hybridized
with the bound sequence and the template specified sequence is copied
enzymatically.
The only comparison of chemical and enzymatically produced columns
was an unintended consequence of a study originally designed to improve upon
the affinity purification of the FadR transcription factor (74). In that study, we
reported that enzymatically prepared columns gave better yield of purified FadR
protein than was obtained with a column prepared by conventional chemical
coupling. This better yield was attributed to enzymatically synthesized DNA all
being accessible to protein binding while chemical coupling may render some of
the DNA inactive or inaccessible. In the same study we also reported that the
protein eluted from the chemically coupled column appeared to be purer by gel
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electrophoresis. Enzymatic synthesis requires an oligo-A: oligo-T primer region
which was unnecessary and not used for chemical coupling. The increase in
length makes enzymatically synthesized columns more complex. This region
could have bound the extra proteins contaminating the FADR protein purified on
the more complex enzymatically prepared support (74). Since this issue of
complexity is poorly understood, we investigated it here and again addressed the
issue of comparing columns produced chemically or enzymatically.
In this report, enzymatic and chemical coupling are compared using the
lac operator DNA sequence and a lac repressor-β-galactosidase fusion protein.
Lac repressor protein, which regulates the lac operon in E. coli , has been well
characterized. Here, a lac repressor-β-galactosidase fusion protein (84)
facilitated accurate assay of the protein, important for determining purity. This lac
repressor-β-galactosidase fusion protein has DNA binding properties comparable
to the native protein (85) (86). Differences in DNA complexity were negated by
coupling the same DNA sequence using chemical and enzymatic coupling
methods. Column dimensions and experimental conditions were also the same.

2.2. Methods
Unless stated otherwise, chemicals were of the highest purity available
from Sigma Chemical Company (St. Louis, MO, USA).
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2.2.1 Enzymatic synthesis
Enzymatic synthesis was essentially by the method described previously
(74) except that Sequenase® 2.0 T7 DNA polymerase (Amersham Corp.,
Arlington Heights, IL, USA) which lacks 3',5'-exonuclease activity was used in
place of the Klenow large fragment DNA polymerase. Briefly, 10 g of moist,
suction dried Sepharose was washed thoroughly with water, 2 g of CNBr was
added to it while stirring, and the mixture was maintained at pH 11 by addition of
5M NaOH until the reaction slowed. The activated Sepharose was then rapidly
washed under vacuum on a coarse sintered glass funnel with 200 ml ice-cold
water and then with 200 ml of 0.1 M NaHC03 pH 8.3, 0.5 M NaCl. Three grams
of the activated Sepharose was reconstituted to 5 ml in the last buffer and 150
nmole of 5' NH2-CH2-CH2-(T)18 DNA was added. The mixture was mixed
overnight on a tube rotator. The support was washed with 4 ml of the NaHC03
buffer and then blocked for 2 hours with 2 ml of 0.1M Tris-Cl, pH 8. The amount
of (T)18 coupled (30 nmole per g of Sepharose) was determined by the
difference in the ultraviolet absorption of added DNA and that recovered from
coupling in the wash fractions.
One gram of (T)18-Sepharose was washed 3 times with 2 ml of
Sequenase buffer (10 mM Tris, pH 7.5, 20 mM MgCl2, 50 mM NaCl) and
resuspended in 2 ml of same buffer containing 45 nmole of T18Op1
(5'GTGGAATTGTGAGCGGATAACAATT(A)18). The mixture was heated to 95°C
and allowed to cool slowly to room temperature with mixing. The support was
then washed 5 times with 2 ml portions of Sequenase buffer. Washes included a
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5 min. incubation on ice with mixing prior to centrifugation. The support was then
washed three times with 2 ml of Sequenase reaction mixture (300 µM dNTP, 5
mM DTT in Sequenase buffer). The Sepharose was resuspended in 2 ml of the
last buffer, 4 µl (52 units) of Sequenase 2.0 was added and the mixture was
incubated at 4°C for 5 min followed by incubation at 37°C for 2 hours. The
mixture was washed with 5 ml of Sequenase buffer, followed by 10 ml TE0.1 (0.1
M NaCl, 10 mM Tris, pH 7.5, 1 mM EDTA) containing 10 mM NaN3 and stored at
4°C until needed. A portion of the support was eluted by washing repeatedly with
boiling water and the amount of complementary strand eluted was determined by
ultraviolet absorption. Support synthesized in this way had 12 nmol double
stranded DNA in the 0.56 ml bed volume column.

2.2.2 Chemical synthesis
Coupling of DNA to Sepharose was by the same protocol used for 5' NH2CH2-CH2-(T)18, described above, except in this case 50 nmol 5’ Op1 T18
(5'NH2-CH2-CH2-(T)18-AATTGTTATCCGCTCACAATTCCAC) was used per
gram activated Sepharose instead. After blocking with 0.1M Tris, pH 8, the
amount of DNA coupled was 33 nmole of Op1 T18. After coupling the DNASepharose was washed with 10 ml TE0.1 (10 mM Tris, pH 7.5, 1 mM EDTA, 0.1
mM NaCl) and reconstituted in 2 ml of the last buffer. 50 nmole of Op1-(A)18 was
added to the mixture and the mixture was heated to 95°C and allowed to cool
slowly to room temperature. It was then washed with TE0.1 containing 10 mM
NaN3 and stored at 4ºC until needed. As with the enzymatic column, a portion of
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the support was eluted with boiling water and the amount of second strand eluted
was determined by ultraviolet absorption. Support synthesized in this way had
11.8 nmol double stranded DNA in the 0.59 ml bed volume column used in. All
oligos were synthesized by standard phosphoramidite chemistry using the
university Molecular Resource Center DNA synthesis facility. 5’ aminoethyl-oligos
were synthesized in a similar manner except the last cycle utilizing the Amino
Link reagent (Applied Biosystems) was included.

2.2.3 Production of lac repressor-β
β-galactosidase fusion protein
Lac repressor-β-galactosidase fusion protein was produced by growing
clone BMH-72-19-1 which was a generous gift of Dr. David Levens (Laboratory
of Pathology, National Cancer Institute, Bethesda Maryland). The clones were
grown overnight in 2 l. superbroth (1.2% bactotryptone, 2.4% Yeast extract, 0.5%
glycerol, 0.072M K2HPO4 and 0.028M KH2PO4) at 37°C and induced for 4
hours with 1 mM IPTG. The cells were pelleted by centrifugation at 8000 rpm for
30 min. in th Sorvall GS-3 rotor The pelleted cells were resuspended in 40 ml
lysis buffer (4 mg/ml lysozyme (Boehringer Mannheim, Indianapolis, IN, USA), 5
mM NaH2PO4, 10 mM, Na2HPO4, 30 mM NaCl, 25 mM benzamidine, 10 mM 2mercaproethanol, 10 mM EDTA, 1 mM PMSF and 0.2% Tween 20). The cells
were lysed by sonication on ice, 30 sec. on followed by 30 sec. off, repeated
three times at setting 12 using a VirSonic 50 sonicator with a microprobe
(Gardiner, NY, USA). Cellular debris was removed by centrifugation at 15,000
rpm for 30 min in a Sorvall SS-34 rotor. The protein was dialyzed against 5 l. of
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TE0.1. This crude protein preparation was stored at -85°C in 1 ml aliquots until
needed.

2.2.4 Chromatography
Two columns, one from the chemically coupled support (0.59 ml bed
volume) and the other from the enzymatically produced one (0.56 ml bed
volume) were packed in 1 ml syringe columns and equilibrated in TE0.1. 500 µl
of crude fusion protein was loaded onto the columns. The columns were washed
with 15 ml TE0.1 and the proteins were eluted with a 20 ml linear gradient from
TE0.1 to TE1.2 (10 mM Tris, pH 7.5, 1 mM EDTA, 1.2 M NaCl). One ml fractions
were collected and the flow rate was maintained at 0.33 ml/min throughout.

2.2.5 Assay of lac repressor−β−
−β−galactosidase fusion protein
Lac repressor−β−galactosidase fusion protein was assayed for
galactosidase activity using Buffer O (3 mM o-nitrophenyl-O−β−Dgalactopyranoside, 0.1 M sodium phosphate, pH 7.5, 1 mM MgCl2 and 45 mM 2mercaptoethanol). 150 µl of buffer O was added to 50 µl of each sample to be
assayed. The reaction was done in a microtiter plate and absorption at 405 nm
monitored continuously at 25°C.

2.2.6 Definition of enzyme units
One unit of lac repressor−β−galactosidase fusion protein is defined here
as that which causes a change of one absorbance unit per min at 25°C.
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2.2.7 Gel electrophoresis
Sodium dodecylsulfate polyacrylamide gel electrophoresis was on 7.5%
gels by the method of Laemmli (87) and stained with silver using a BioRad
Laboratories (Richmond, CA, USA) kit.

2.2.8 Protein assay
Protein concentrations were determined by bicinchoninic acid method
using the protocol provided by Pierce Chemical Co. Samples were precipitated
with ice-cold 10% trichloroacetic acid and reconstituted in a reduced volume of
2% Na2CO3 in 0.1 M NaOH before assay.

2.3. Results
We had hypothesized previously that the complexity of a column attached
DNA would affect the purity obtained in transcription factor purification (74). As a
DNA sequence becomes more complex we reasoned that other sequences are
produced which may be bound by other cellular proteins. Since a common
practice in transcription factor purification is to use long concatemers (produced
by ligating oligonucleotides to produce long stretches of DNA) containing multiple
copies of the binding site (78) this issue of complexity could be quite important.
Figure 2.1 shows that indeed DNA complexity does affect transcription factor
binding but not quite in the way we envisioned.
The Op1 operator sequence used here and in Figure 2.2 is a 25-mer. It is
shown in Figure 2.3. The complementary strand DNA (i.e., αOp1) was
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Absorption, 405 nm
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Figure 2.1. The length of coupled DNA affects retention of laciz.
Each of the three DNA’s shown was chemically coupled to CNBractivated-Sepharose and a 1 ml syringe column packed. Additions in each case
were to the 3’ end of the Op1 sequence (see Figure 2.3), at the same end of the
double stranded DNA where the 5’-aminoethyl group on the complementary
strand would be found. The amount of DNA coupled was 16 nmol/g Sepharose
for Op1 and 32 nmol/g for the other two. For each column, 0.5 ml of the crude
laciz bacterial extract was loaded. Elution was with 10 ml of constant TE0.1,
followed by a linear gradient of 20 ml from TE0.1 to TE1.2, followed by 20 ml of
constant TE1.2. One ml fractions were collected and assayed for β-galactosidase
activity (absorption 405 nm).
34

Absorption, 405 nm

0.15
5'Op1-T6
5'-T3-Op1-T3

0.1

5'-T6-Op1
0.05
0
0

10

20

30

40

50

Fraction number

Figure 2.2. The position of additional sequences also affects retention.
For each of the DNA’s, six additional adenylate residues were added, but
the position was different as shown in the figure. The columns were all 1 ml and
contained 26, 30, or 29 nmol DNA/g Sepharose for 5’-T3-Op1-T3, 5’-Op1-T6 and
5’-T6-Op1respectively. The columns were loaded and eluted as described for
Figure 2.1.
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Figure 2.3. Schematic representation of enzymatic and chemical DNASepharose synthesis.
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synthesized with a 5’-aminoethyl group using the AminoLink reagent. It was
directly coupled to Sepharose using CNBr activation, and annealed to the Op1
strand. Since this DNA lacks an oligoA: oligoT region, we have called it Op1 in
the figure. The same DNA sequence was also synthesized containing either a six
or an eighteen long 3’-oligothymidylic acid “tail” on the Op1 strand (and a
complementary 5’-oligothymidylic acid tail on the other strand). These DNA’s
were also coupled and are called Op1T6 and T18 in the figure. To test columns
prepared from these DNA sequences, a crude bacterial extract containing a
chimeric fusion protein (laciz) of lac repressor (i.e., laci) and β-galactosidase (i.e.,
lac z) was applied to each column and eluted using a salt gradient. The column
fractions were then assayed for β-galactosidase activity in an assay, which
results in an increased absorption at 405 nm for active fractions. While lac
repressor would be expected to have high affinity for the Op1 sequence, it should
have minimal affinity for the unrelated homopolymeric sequences and yet clearly
these sequences do affect retention as shown in Figure 2.1. Since the presence
of T6 or T18 increases retention time, this sequence must increase the overall
affinity of the repressor for the stationary phase DNA.
Furthermore, the position and distribution of homopolymeric sequences
can also affect retention as shown in Figure 2.2. In this experiment, six
thymidylate residues were added to one end or the other of the Op1 sequence,
or three residues was added to each end. The corresponding number of
adenylates were added to the complement strand. The results show that
additions of three residues to each end give lower retention times than is
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obtained by adding six residues to either end and that, furthermore, additions to
the 3’-end of the Op1 sequence give the highest retention time of all.
Peak heights are also different in Figure 2.1 and Figure 2.2 but this is due
to differences in the amount of DNA coupled to each column which affects the
capacity of the columns for laciz. We have found that the amount coupled, while
affecting capacity does not affect retention times for salt gradient elution though
(data not included). These differences in retention are due to the DNA complexity
and were consistently observed with columns containing different amounts of
coupled DNA.
From these results it is clear that minor differences in sequence, even with
unrelated homopolymeric regions, can affect retention. Thus, to find out if the
differences previously observed for chemically and enzymatically produced
columns (74) were due to the method of synthesis or to differences in sequence,
we prepared columns by both procedures using the same DNA sequence. The
scheme used for column synthesis is depicted in Figure 2.3. Columns prepared
by chemical and enzymatic synthesis depicted in the figure would have identical
double stranded DNA, despite differences in how they were synthesized.
Figure 2.4 shows the elution of laciz fusion protein from chemically and
enzymatically synthesized columns. Both columns were the same dimensions
and contained virtually identical amounts of the same double-stranded DNA
sequence; they differ only in how they were produced. It can be seen that both
columns have similar properties in terms of amount of fusion protein they bound
and eluted. However, we also found that the repressor elutes at slightly lower salt
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Figure 2.4. Enzymatically and chemical synthesized supports show
similar chromatography.
Synthesis was as depicted in Figure 2.3 and described in Methods. The
enzymatically prepared column was 0.56 ml bed volume and contained 12 nmol
double stranded DNA; the chemically prepared column was 0.59 ml and
contained 11.8 nmol double stranded DNA. Flow rate was 0.33 ml/min and 1 ml
fractions were collected. The elution was with a gradient of constant TE0.1 for 90
min, a linear increase to TE2.0 (10 mM Tris, pH 7.5, 1 mM EDTA, 2 M NaCl) at
230 min, followed by 20 min of constant TE2.0.
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concentration from the enzymatic column. The peak fraction elutes from the
enzymatic column at 0.7 M NaCl (determined by conductivity) while the peak
fraction from the chemical column elutes at 0.8 M. This result was reproducible in
all our chromatographic runs and with columns made at different times and
containing different amount of DNA coupled but its cause is unknown.
Figure 2.5 shows an acrylamide gel of fractions obtained from the
chemical and enzymatic columns. A protein band corresponding to the expected
molecular mass (84) of the lac repressor−β−galactosidase fusion protein (155
kDa) can be seen in both fractions and is indicated by the arrow. This band, and
two prominent bands just below it (indicated by lines) all stain with an anti-lac
repressor antibody (data not shown). Thus, the full length fusion protein and at
least two truncated forms of it are bound by and elute from both columns. Only a
single, minor band (indicated by an asterisk) is unique to the enzymatic column
and the purity of both fractions is comparable.
Table 2.1 shows a balance sheet for the average purification and yield of
protein eluted from the two columns. Yield and purity are virtually identical for the
two columns. Since the columns were loaded with an excess of the fusion
protein, the yield is a measure of column capacity in this experiment. Thus,
column capacity is virtually identical for the two types of columns. The purification
was repeated three times with each column and the results were averaged and
compared statistically. There is no statistically significant difference between the
yield or purity obtained with either column.
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Figure 2.5. Electrophoresis demonstrated that purity is similar for proteins
purified on the chemical and enzymatic columns.
Crude bacterial extract containing the laciz fusion protein was purified on
the chemical (C) and enzymatically (E) produced column using the conditions in
Figure 2.4. The peak eluted fractions were pooled, concentrated, and applied to
a 7.5% sodium dodecylsulfate polyacrylamide gel [10]. The position of molecular
weight markers, in kilodaltons, are shown to the left of the gel. Other symbols are
described in the text.
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Table 2.1. Balance sheet for purification on chemically and
enzymatically produced DNA-Sepharose columns.

Fraction

Total Activity,

Total Protein, mg

Yield, %

units

Purification,
fold

Crude

2.3 ± 0.1

5.2 ± 1.2

100

1

Chemical

0.62 ± 0.33

0.014 ± 0.004

33 ± 13

93 ± 20

Enzymatic

0.68 ± 0.44

0.020 ± 0.014

33 ± 13

82 ± 23

P = 0.50

P = 0.28

a

Shown are averages ± the standard deviation for three (N=3) different

experiments on each column.
P= probability that the means for the chemical and enzymatic columns are
the same.
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2.4. Discussion
In a previous report from our lab (83) we had reported that a chemically
synthesized column yielded purer FAD R protein while more protein could be
recovered from the enzymatically synthesized column. However, the DNA
sequence on the two types of columns was not the same. The enzymatic
synthesis required a T18:A18 primer region not necessary or used for chemical
coupling. Since the operator B sequence bound by FAD R in those experiments
is a 30-mer, this difference amounted to coupling a 30-mer chemically or copying
a 48-mer enzymatically. This makes the enzymatically produced column more
complex. If this additional DNA sequence could bind other proteins, this could
account for the lower purity. To answer this, here we chemically coupled the
same DNA sequence used for enzymatic column production. Under these
conditions, there is no difference in the purity obtained. In our studies with the
purification of the lac repressor−β−galactosidase fusion protein, when identical
DNA-Sepharose columns are produced by the two methods, both types of
columns behaved almost identically and neither of the columns had an
advantage in terms of yield or fold purification. The only difference found was that
the protein eluted at a slightly lower salt concentration from the enzymatic
column than from the chemical column. We do not understand the mechanism
behind this behavior but it doesn’t seem to be important to the chromatography.
While the method of synthesis was not important in this study, the exact
sequence and complexity of DNA coupled was shown to be very important. Here,
we show that even simple, homopolymeric sequences can have marked effects
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on column performance and retention times. Why this is so is not known but
could arise in at least two ways. Base pairing involves weak forces, primarily
hydrogen bonding, stabilizing the double-stranded DNA structure. As DNA is
heated, these weak forces are ultimately insufficient to resist thermal motion and
at some temperature, DNA becomes single stranded. This “melting” temperature
was never exceeded in our experiments. Even at lower temperatures though, the
ends of a double-stranded DNA are not stabilized by as much hydrogen bonding
as occurs mid-strand, base stacking is more solvent exposed, and localized
“melting” or fraying of the ends can occur. If sequences near the end are
important to transcription factor binding, this fraying could adversely affect
binding. Footprinting with DNAase I (88) shows that lac repressor binds to the
DNA shown in Figure 2.3 covering the entire sequence shown except for the last
three base pairs at each end (indicated in the figure). By adding additional DNA
to the ends, the fraying is distanced from the binding site and an intact binding
site is maintained. Thus, the homopolymeric sequenced could prevent thermal
denaturation of more distal regions of the operator DNA sequence.
The other potential explanation involves what is frequently referred to as
“sliding” (26). It has been observed that lac repressor and operator 1 DNA
associate at a rate of about 100-fold faster than three dimensional diffusion
should allow (89). Lac repressor also binds “non-specific” (i.e., non-operator 1)
DNA sequences with relatively high affinity. For example, under low ionic
strength conditions, the dissociation constant for operator 1 is about 5 x 10-14 M
while the constant for “non-specific” (alternating poly(AT) DNA) is about 10-9 M.
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This led to the hypothesis that the repressor may bind from bulk solution (i.e., 3dimensional diffusion driven) to any non-specific DNA sequence and then slide
(i.e., 1-dimensional diffusion) along the helix until the operator is encountered
and bound (90)]. In fact, any of several other mechanisms which restrict the
dimensionality of diffusion would accomplish the same enhancement of rate;
what is necessary is that binding be a two step process involving “non-specific”
binding followed by a “sliding”, “hopping”, or “bridging” step which restricts
diffusion to less than three dimensions (26) (27). The dependence of Op1binding of lac repressor on both salt concentration and DNA length agrees with
what would be predicted for such a sliding mechanism (27) (88) (91) (92) (93).
While long DNA sequences (> 70 bp) do affect association rates in a way
consistent with a sliding mechanism (93) any affect of shorter lengths is unclear
and may not be measurable by current binding assay methods. Since lengths as
short as six bp do affect our chromatography, chromatography may provide an
even more sensitive method for measuring limited diffusion affects on proteinDNA binding.
Whether either of these possible explanations (melting stabilization or
sliding) accounts for the current results is not currently known but is being
investigated. However, it is interesting to note that enhanced lac-repressor
binding to poly AT DNA had been noted using filter binding assays as far back as
1970 (94) is in agreement with the data presented here.
Another possible way that additions to the ends of DNA sequences could
contribute to column performance is by acting as a spacer, distancing the
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operator sequence from support surfaces which could sterically inhibit binding.
This seems unlikely to explain the results here. Cyanogen bromide-activated
Sepharose can couple directly to nucleic acid bases, presumably adenine,
guanine, or cytosine (95). Here, we have introduced a 5’-aminoethyl moiety
which should provide a favored coupling site but coupling elsewhere would
presumably also occur. While this issue has not been directly investigated for
CNBr-activated Sepharose, it was shown with activated ester coupling that
coupling is predominantly through the aminoethyl but that some base
modification also occurs (81). The DNA strand which was chemically coupled in
the present report was always the αOp1 strand containing a 5’-aminoethyl group
and any poly(T) sequences necessary to complement poly(A) regions on the
complement strand. This was done since T is unreactive for coupling and so the
added regions were not providing additional coupling sites. Thus, reaction can
occur at the 5’-end or intrachain but not within the homopolymeric sequences
introduced. An aminoethyl group would contribute about 5 Å spacing and each
base pair in the DNA helix contributes 3.4 Å. The lac repressor binding site
(DNAase I footprint) is three base pairs from either end. Thus, aminoethyl
coupled Op1 would place the binding site about 15 Å from the Sepharose surface
and, for example, (T)6 would add an additional 20 Å. In Figure 2.2, the sequence
5’-T6-Op1 has the homopolymeric region on the same end of the DNA as the
aminoethyl moiety and the spacer length would be about 35 Å; while Op1-T6-3’
has the same sequence at the opposite end and a spacer length of about 15 Å.
Either of these gave greater retention than the T3-Op1-T3 (spacer length about 25
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Å). Thus, spacer length does not correlate with retention.
While the mechanism by which DNA complexity affects retention time is at
present unclear, the effect is undoubtedly useful in transcription factor
purification. Our previous study of FadR showed that purification on columns of
different complexity impacted both yield and purity (74). Others have reported
that highly complex DNA, composed of concatemers of ligated oligonucleotides
are necessary for effective purification of some transcription factors (78) (77).
Since complexity alters retention time (Figure 2.1 and 2.2), it also affects
resolution of a specific transcription factor from other cellular DNA-binding
proteins. Careful characterization of this complexity effect should greatly benefit
our understanding of this affinity chromatography and improve protein
purification.
Enzymatic synthesis has an inherent disadvantage in being more
cumbersome than chemical coupling. Hence, chemical synthesis seems to be
preferable for purification of lac repressor and probably other transcription
factors. However, enzymatic synthesis does have other advantages. Techniques
are available for producing columns enzymatically from either RNA (82) (83) or
DNA templates (81) and the DNA support produced can be directly sequenced
(83). Furthermore, since chemical coupling procedures modify nucleic acid bases
while the milder enzymatic synthesis does not, it may prove more useful for the
purification of proteins whose DNA binding affinity is more sensitive to chemical
modification such as, for example, proteins involved in DNA repair.
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Appendix
Robinson, F. D. who is also the co-author of paper on this work (75) has
contributed data for the Figures 2.4 and 2.5 in this chapter.
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Chapter: 3. Comparative studies on discrete and
concatemeric DNA-Sepharose columns for purification of
transcription factors

Part of this chapter was published in Journal of Chromatography (2001) in
press. Permission was obtained from the publisher to use our published article in
the dissertation. Some variations in format were adapted for the dissertation.
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3.1. Introduction
Transcription factors and other DNA binding proteins are often present in
cells in small amounts. Hence, purification of these proteins from cellular extracts
is frequently difficult and involves several chromatographic steps. DNA affinity
chromatography offers greater specificity and selectivity than any other
chromatographic process and hence is frequently use in purification of these
proteins (78) (74) (76).
Each transcription factor binds to a specific DNA element, which can be
identified by endonuclease or chemical footprinting techniques. Specific
sequence DNA affinity columns are made by covalent coupling of the specific
DNA element to a variety of solid supports such as silica, Sepharose or cellulose
(76) (78). Such columns are bound with greatest affinity by the protein of interest
and can be used for its purification.
DNA columns containing tandem repeats of the footprint element, i.e.,
concatemers, were first used for purification of the Sp1 transcription factor (21)
(77). Sp1 binds a GC-rich decanucleotide, the GCbox. The early promoter of the
SV40 virus contains six tandem copies of the GCbox and Sp1 binding activates
SV40 transcription. Thus, the use of concatemer GCbox for the purification of
Sp1 followed rationally from the promoter structure. However, since the
successful purification of Sp1, concatemer DNA columns have become widely
used for purification of other transcription factors. Indeed, in 1991 at least fifty
transcription factors had been purified using concatemers (78). Concatemers are
usually made by ligating single copy DNA strands having a complementary
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overhang sequence. Catenating DNA makes it more complex and can introduce
new DNA sequences (that are not part of the element but are necessary for
ligation) which may bind other, additional DNA binding proteins as shown in
Figure 3.1. Furthermore, it is difficult to control the ligation reaction and thus
concatemeric columns are, of necessity, a heterogeneous mixture of different
lengths, which also could adversely affect chromatographic resolution. There is
currently no report that critically investigates whether concatemer columns are
better than simpler strategies for transcription factor purification.
Lac repressor protein is a regulatory protein, which controls the
expression of the lac operon in E. coli. The lac repressor has been widely studied
and the operator 1 (Op1) region of the DNA to which it binds has been well
characterized (96). CAAT enhancer binding protein-α (C/EBP) is another widely
studied protein, which is found ubiquitously in mammals; it binds to the CAAT
element and regulates the expression of several developmental and viral genes
(22) (66). In both these cases, the transcription factor binds well to discrete DNA
columns and thus concatemers have not been used and any beneficial effects of
concatemers on their purification is untested. However, it is known that adding
simple homomeric sequences (e.g., T18: A18 tails) increases retention of lac
repressor (75) suggesting that more complex DNA sequences may prove
beneficial.
In this paper, we have used green fluorescent protein-CAAT enhancer
binding protein (GFP-C/EBP) and a lac repressor-β-galactosidase fusion protein
(laciz) to compare the properties of discrete, concatemeric, and T18: A18-tailed
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Figure 3.1. Schematic representation of the strategy used for production
of concatemeric DNA sequences.
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DNA columns. Both fusion proteins have DNA binding properties comparable to
the native transcription factors (84) (97) (98). Here, we show that for some
proteins such as GFP-C/EBP, discrete DNA columns give better purity and yield
than the concatemeric columns. For other proteins such as laciz, which has a
lower affinity for discrete columns, T18: A18-tailed DNA columns give better
resolution than discrete or concatemeric columns. We also show that Sp1 can
bind to discrete, concatemeric and T18: A18-tail columns with similar affinity.

3.2. Methods

3.2.1 DNA Sepharose preparation
The oligonucleotide shown in Table 3.1 were used for making DNA affinity
columns. All strands having Aminolink were coupled to CNBr-preactivated
Sepharose 4B (Sigma Chemical Co.). Coupling and end-capping were carried
out according to the protocol provided by the manufacturer. Op1, Op1T18 and
(Op1)4 columns were made double stranded by adding the corresponding,
complementary strand. The mixture was then heated to 95°C and allowed to cool
slowly to room temperature. (EP18)5 is self complementary and does not require
the addition of a second strand.
Complementary strands of GCbox and GCboxT18 were annealed before
coupling. The concatemeric (GCbox)n DNA sequence was made by kinasing both
oligonucleotides and ligating them as described by Kadonaga (77). A schematic
description of concatemer formation is given in Figure 3.1. A mixture of oligomers
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Table 3.1. Oligonucleotides used for making DNA affinity columns.

Name

Sequence of strand which was coupled

Sequence of complementary strand

Op1

5'-

5’GTGGAATTGTGAGCGGATAAC
AATT**

NH2AATTGTTATCCGCTCACAATTC
CAC**
Op1T18

5’GTGGAATTGTGAGCGGATAAC

5'-NH2-(T)
18AATTGTTATCCGCTCACAATTCCA

AATT(A)18

C
(Op1)4

5'-

(5’GTGGAATTGTGAGCGGATAAC

NH2(AATTGTTATCCGCTCACAATTC

AATT)4

CAC)4
EP18

5'-NH2GCAGATTGCGCAATCTGC

NA*

(EP18)5

5'-NH2-(GCAGATTGCGCAATCTGC)5

NA*

GCbox

5’-NH2GGGGCGGGGC

5’GCCCCGCCCC

GCboxT18

5’-NH2--(T) 18GGGGCGGGGC

5’GCCCCGCCCC(A)18

(GCbox)n

5'-GATCGGGGCGGGGC

5'-GATCGCCCCGCCCC

* NA stand for not applicable, EP18 and (EP18)5 are self complementary
and do not require the addition of a second strand.
** A CAAT element is present in both the strands of Op1 sequence.
“5’NH2“ represents aminoethyl group added on the last synthetic cycle
with the Aminolink reagent (Applied Biosystems)
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containing 1 to 20 copies of the original sequence was obtained as determined
by their mobility on agarose gel. This mixture was then used for coupling. The
amount of DNA coupled was determined by the difference in absorption of DNA
added before and recovered after coupling. For each gram of CNBr-activated
Sepharose, the amount (nmol) of DNA added, the amount which coupled per
gram of Sepharose, and the percent coupling are: EP18 (26.5 nmole, 21 nmol,
80%), (EP18)5 (16.2, 4.9, 30%), Op1 (41.6, 19.5, 47%), Op1T18 (42, 11, 26%),
(Op1)4 (57, 6, 11%), GCbox (36, 14.9, 40%), and GCboxT18 (20, 5.7, 30%). For
(GCbox)n, molecular weight is not applicable; and per gram of Sepharose, 88 µg
DNA was added, 37 µg coupled, for a yield of 42%. In the same units, this is
comparable to the 43 µg and 49 µg coupled per gram of the GCbox and
GCboxT18, respectively. All columns were stored at 4°C in TE0.1 buffers (10 mM
Tris, pH 7.5, 1 mM EDTA, 0.1 M NaCl) containing 10 mM NaN3 when not in use.

3.2.2 Production of proteins
Lac repressor-β-galactosidase fusion protein was produced as described
earlier (60) by growing clone BMH-72-19-1, which was the generous gift of Dr.
David Levens (Laboratory of Pathology, National Cancer Institute, Bethesda,
Maryland). The protein is used as a dialyzed crude extract (4.7 mg/ml) containing
1-1.5% of total protein as laciz. GFP-C/EBP was produced by growing E. coli
strain BL21 containing plasmid pJ22-GFP-C/EBP as described previously (98).
The crude bacterial extract (2.9 mg/ml, 1.4-2% of which is GFP-C/EBP)
was used for the purification experiments. The protein was also purified by Ni2+55

NTA-agarose (Qiagen) as described (98).
HeLa cell nuclear extract (1.8 mg/ml) used for studies on Sp1 was
obtained by the procedure in (77).

3.2.3 Chromatography
All columns were 1 ml bed volume syringe columns initially equilibrated in
TE0.1 buffer. Crude preparations of laciz (bacterial extract, 4.7 mg/ml), GFPC/EBP (bacterial extract, 2.9 mg/ml), Sp1 (HeLa cell extract, 1.8 mg/ml) or
purified preparations of GFP-C/EBP were loaded onto the appropriate columns.
Unless otherwise stated, all columns were then washed with 10 ml of TE0.1 and
were eluted with a 20 ml gradient from TE0.1 to TE1.2 (10 mM Tris, pH 7.5, 1
mM EDTA, 1.2 M NaCl). The flow rate was 0.5 ml/min and 1 ml fractions were
collected.

3.2.4 Assay of fusion proteins
GFP-C/EBP was assayed by measuring fluorescence as described earlier
(98). Laciz was assayed for β-galactosidase activity by mixing 150 µl of Buffer O
(3 mM o-nitrophenyl-β-D-galactopyranosidase, 0.1 M NaH2PO4, 1 mM MgCl2
and 45 mM β-mercaptoethanol) with 50 µl of each fraction to be assayed. The
reaction was carried out on microtiter plates and monitored continuously at 25°C
for absorption at 405 nm.
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3.2.5 Protein assay
Protein concentrations were determined by the bicinchoninic acid method
using the protocol provided by Pierce Chemical Co. All samples were
precipitated with 10% ice-cold trichloroacetic acid (TCA) and re-dissolved in 2%
Na2CO3, 0.1 M NaOH before assay.

3.2.6 Blotting experiments
0.6 ml of each column fraction was applied to 0.45 µm pore nitrocellulose
filter paper in a BioRad Slot-Blot apparatus, allowing the samples to slowly
percolate through the filter under gravity. The membrane was then washed three
times with 0.6 ml portions of TBS (20 mM Tris, pH 7.5, 0.5 M NaCl). The filter
was blocked overnight with 10 mg/ml bovine serum albumin in TTBS (TBS that
additionally contains 0.05% Tween 20). Next day, the membrane was washed
three times with BSA/TTBS (1mg/ml bovine serum albumin in TTBS). The filter
was incubated for 60 min in 1:3000 dilution of a polyclonal antibody specific for
Sp1 ((PEP 2)-G, goat polyclonal IgG obtained from Santa Cruz Biotechnology). It
was then washed three times with BSA/TTBS and incubated in a 1:3000 dilution
of alkaline phosphatase rabbit anti-goat IgG conjugate supplied by Pierce. The
membrane was washed three times with BSA/TTBS and then stained for alkaline
phosphatase using a kit supplied by Promega Co. (Madison, WI, USA). For some
experiments, the blots were quantified by densitometry. The blot was scanned on
a Hewlett Packard ScanJet 6100 scanner and the resulting image densities
calculated using NIH Image.
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3.2.7 Polyacrylamide gel electrophoresis
All samples were concentrated using Centriplus centrifugal filter devices
supplied by Milipore Corporation (Bedford, MA, USA). One fourth of each sample
was applied to sodium dodecylsulfate polyacrylamide 4-15% Bio-Rad precast
gradient gels using the method of Laemmli (87) and stained after electrophoresis
with silver using the Bio-Rad Laboratory kit (Richmond, CA, USA).

3.3. Results and discussion
Figure 3.2 shows elution of highly purified GFP-C/EBP from the EP18 and
the (EP18)5 columns, the latter containing 5 copies of EP18 arranged as tandem
repeats. The elution profile of the protein from the two columns looks similar and
the protein is eluted at a NaCl concentration between 0.65-0.9 M. There is a
small difference in the retention times and the proteins elutes at a slightly greater
salt concentration from the (EP18)5 column than from the EP18 column. This
difference was consistently observed in all experiments. Both columns behave
similarly and bind nearly the same amount of the purified GFP-C/EBP.
When a crude bacterial extract was used, the results are different in some
respects. The purity and yield of GFP-C/EBP obtained from the EP18 and
(EP18)5 columns is compared in Table 3.2. Such crude extracts contain other
fluorescence which prevents determining the amount of GFP-C/EBP in the
extract, however, by loading the same amount on each column, the results of the
two columns could be compared. The amount of GFP-C/EBP obtained from the
EP18 column was significantly greater than that obtained from the (EP18)5
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Figure 3.2. Elution of GFP-C/EBP from EP18 and (EP18)5 columns.
100 µl of purified GFP-C/EBP was loaded on 1 ml EP18-Sepharose (solid
line) or (EP18)5 (dashed line) column. Chromatography was performed as
described in section 3.2.3
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Table 3.2. Balance sheet for purification of GFP-C/EBP from EP18
and (EP18)5.

Sample

EP18

(EP18)5

P

Total Fluorescence

6.4 ± 0.6a

3.8 ± 0.8

0.008b

752 ± 76

596 ± 138

0.08

(relative fluorescence in
volts)
Specific Activity (volts/mg
of protein)

a

The results of three experiments were averaged (n=3) and averages are

reported for all columns. For each experiment 500 µl of crude bacterial extract
containing GFP-C/EBP was loaded onto a 1 ml EP18 or (EP18)5-Sepharose
column. The columns were then washed and eluted as described in the section
3.2.3. Active fractions were pooled for assay.
b

The probability (P) that the averages shown in the row are not different is

given.
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column with P= 0.008 (i.e., significantly different at the 0.8% confidence level).
The protein obtained from the discrete EP18 column also had a higher specific
activity though not significant with P= 0.081 (i.e., different at an 8% confidence
level). The decreased yield for (EP18)5 could be because of binding of other DNA
binding proteins to the new sites (i.e., the DNA sequences between footprints in
the concatemers, see Figure 3.1) that are created by oligomerization of the EP18
sequence.
Alternatively, the chemical synthesis of an 18-mer (EP18) should yield
more homogeneous product while synthesis of a 90-mer such as (EP18)5 may be
more heterogeneous, containing fore-shortened sequences as a consequence of
less than 100% efficiency at each step of synthesis. These fore-shortened
sequences may have imperfect elements which function poorly or not at all.
Since DNA complexity had little effect on retention time (Figure 3.2), other
ways of generating complex DNA (i.e., tailing) were not investigated.
As a consequence of characterizing columns prepared by enzymatic
primer extension (75) we had shown before that binding of lac repressor protein
to its operator is improved by addition of polyA:polyT tails of different length. In
Figure 3.3, it can be seen that the Op1 column, containing discrete operator,
binds weakly and has a lower retention time for laciz than the (Op1)4 column
containing four tandem repeats of Op1 or the Op1T18 column which contains Op1
with a T18: A18-tail. The increased binding affinity of (Op1)4 and Op1T18 could be
because of an effect of longer, more complex DNA on retention times as
discussed in more details elsewhere (75). Interestingly, the more complex
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Figure 3.3. Elution of laciz from the Op1, the Op1T18 and the (Op1)4
columns.
100 µl of crude bacterial extract, containing laciz, was loaded onto a 1 ml
Op1, (dashed line), Op1T18 (bold line), or (Op1)4-Sepharose (solid line).

62

columns also appear to resolve more than one species of lac repressor fusion
protein. Previously (75) we had shown this sample to contain several proteolyzed
forms of laciz which may account for the peaks resolved on the (Op1)4 or Op1T18
columns.
The purity of laciz obtained from the three columns was assessed on a
polyacrylamide gel. It can be seen from Figure 3.4 that laciz (indicated by the
larger, darker arrow near the top of the gel) obtained from Op1T18 column (lane3)
has similar purity to that obtained from the concatemer column (lane 4) and
higher purity than was obtained from the discrete, untailed column (lane 2).
Another interesting observation is that all three columns behave differently and
some of the contaminant bands (indicated by the lighter, smaller arrows) in the
three column runs are different. Hence using some combination of these three
columns in sequence would probably get rid of some of the contaminant proteins
and give higher purity than any column alone would accomplish. The T18:A18 tail
and catenation seem to function similarly by increasing the complexity of the
DNA and this results in an increase in the retention time of laciz on the columns;
increased retention time may allow weakly binding contaminants to wash from
the column before the protein of interest elutes. Different purity of laciz was
obtained from similar columns in other experiments (Chapters 2 and 4). These
differences were observed because only the peak fractions were used in other
experiments while all the active fractions were pooled here. Moreover variations
in expression levels of laciz during production of crude extracts could also lead to
differences in the purity obtained.
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Figure 3.4. Purity of laciz from the Op1, the Op1T18 and the (Op1)4
columns.
500 µl of crude bacterial extract (same as in Figure 3.3) containing laciz
was loaded onto a 1 ml Op1, Op1T18 or (Op1)4-Sepharose. Lane 1 shows 100
times diluted crude extract while lanes 2, 3 and 4 represent proteins obtained
from Op1, Op1T18 and (Op1)4-Sepharose, respectively. The big arrow indicates
the laciz protein The smaller arrows indicate contaminant proteins that are
unique in different column runs. The numbers on the left indicate molecular
weight (in Dalton) of standards run on the same gel.
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Figure 3.4 shows that for Op1, and presumably for other DNA sequences
as well, many different proteins can bind to the DNA. One way this could happen
would be if two transcription factors bound elements that are both present in the
column DNA. In fact, in our limited study of less than a half-dozen transcription
factors, we have found two that bind to the Op1 DNA - C/EBP and laciz (60).
Since we found a case in such a small group of proteins, this is likely to be a very
common phenomenon. In this case, the Op1 sequence contains a CAAT element
bound by C/EBP (see the bold sequence in the Table 3.1). To model the ability of
simple and complex columns to separate such protein mixtures, we combined
laciz and GFP-C/EBP. It can be seen from Figure 3.5A that the Op1 column
shows poor resolution of the two proteins with R = 0.143. R, the resolution factor,
is the ratio of the separation between the two peaks divided by the mean peak
width. A value of R greater than 1 represents complete peak separation and
values less than 1 indicates partial overlap with a value of 0 indicating complete
overlap. The Op1 column has the biological DNA sequence that is specifically
bound by lac repressor but surprisingly GFP-C/EBP binds more tightly to this
column than laciz and is eluted at a higher salt concentration than laciz. As can
be seen from the figure, it would be difficult to separate the two proteins with a
salt gradient.
Figure 3.5B shows the resolution of GFP-C/EBP and laciz on the (Op1)4
column. It can be seen that now laciz elutes later than GFP-C/EBP but the
resolution of the two proteins is still poor with R = 0.133, primarily because the
peaks are broad on this concatemer column. Broad peaks could result from a
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Figure 3.5. Resolution of laciz and GFP-C/EBP on different DNASepharose columns.
100 µl of crude laciz (same as Figure 3.3) was mixed with 100 µl of
purified GFP-C/EBP and loaded onto Op1(panel A), the (Op1)4, (panel B) or the
Op1T18 column,(panel C). Fluorescence of GFP-C/EBP for early fractions is not
shown because of interfering fluorescence of crude cell constituents flowing
through the column.

66

120

A

100
80
60

100

LacIZ

80

GFP/CEBP

60

%TE1.2

40

40

%TE1.2

Relative units of LacIZ or
GFP-C/EBP

120

20

20

0

0

-20
0

10

20

30

40

120

120
100

B

100
80

LacIZ

60

GFP/CEBP

80
60
40
20

%TE1.2

40
20

% TE1.2

Relative units of LacIZ or
GFP-C/EBP

Fraction number

0
-20

0
0

10

20

30

40

120

C

100
80

LacIZ

60

GFP/CEBP

40

%TE1.2

20
0
0

10

20

30

Fraction number

67

40

120
100
80
60
40
20
0
-20

% TE1.2

Relative units of LacIZ
or GFP-C/EBP

Fraction number

heterogeneous stationary phase which is to be expected for this 100-mer DNA,
heterogeneous because of sequence fore-shortening as described above.
Of all the three columns Op1T18 column gives the best resolution with R =
0.4 (Figure 3.5C). The better resolution is because of greater time differences in
the retention time and because the peaks of laciz and GFP-C/EBP eluted from
the Op1T18 column are sharper than those eluted from (Op1)4 column. The latter
is probably a result of the more homogeneous DNA resulting from synthesis of
this 43-mer. Thus, Figure 3.5 reveals the basis of the selectivity differences
observed in Figure 3.4. As the length and complexity of the column attached
DNA is altered, so is the retention of each of the proteins bound, the protein of
interest as well as contaminants. Thus, a contaminant may co-elute or not with
the protein of interest depending upon the exact DNA sequence used. Resolution
is also affected by the homogeneity of the stationary phase. Tailed DNA because
it is relatively short can be made chemically and in high yield. Concatemers are
longer and their chemical synthesis yields shortened forms because of less than
100% efficiency of each synthesis step. Concatemers produced by ligation would
also be heterogeneous mixtures. This contributes heterogeneity to the stationary
phase and this probably accounts for the lower resolution of concatemers
compared to tailed sequences.
Concatemeric columns were first used for the purification of the
transcription factor Sp1. We investigated whether catenated (GCbox)n columns
made specifically to bind Sp1 behaved differently than the corresponding discrete
(GCbox) or GCboxT18 columns. This would certainly be the case if, as previously
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reported, Sp1 binds best to concatemer columns (77). To our surprise Sp1 binds
to all three columns equally well (Figure 3.6) and can be seen eluting in fractions
13 to 21 (0.4 – 0.75 M NaCl) from all three columns. We do not find any apparent
differences in the affinity of Sp1 for GCbox, (GCbox)n or GCboxT18 columns and
the protein eluted in the same fractions from all three columns. While Figure 3.6
shows that the elution behavior was similar for all three columns, Figure 3.7
shows that GCboxT18 column gives a better yield of Sp1 than either GCbox or
(GCbox)n columns. For this experiment the active fractions from the three
columns were each pooled, two-fold serial dilutions of each pool were made and
blotted onto nitrocellulose paper and Sp1 was detected with a specific antibody.
It can be seen from the figure that a similar amount of Sp1 elutes from the
GCbox and (GCbox)n columns but the amount eluted from the GCboxT18 column
is about four-fold higher. This GCboxT18 column had 14-32% more DNA coupled
to it (see the Methods section) than the GCbox or (GCbox)n columns, but that
alone cannot account for the four-fold increase in protein obtained from
GCboxT18 columns. The higher yield obtained with the GCboxT18 column could
be because the T18 tail acts as an inert spacer, making more of the element
accessible. Alternatively, the length of this DNA may facilitate binding by a sliding
model mechanism we discussed previously (75). The (GCbox)n column, on the
other hand, has several tandem repeats of the GCbox. Ligation introduces
additional DNA sequences in the inter-footprint sequences used for ligation as
can be seen from Figure 3.1. These additional sequences may be binding sites
for other DNA binding proteins; and the binding of these proteins to the DNA
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Figure 3.6. Elution of Sp1 from different GCbox columns.
500 µl of HeLa Cell nuclear extract was loaded onto a 1 ml GCbox, (Gc
box)n, or GCboxT18-Sepharose column. 600µl of each fraction (1 ml) was blotted
onto nitrocellulose paper using Biorad slotblot apparatus and probed with anti
Sp1 (PEP 2) antibody. Intensity of color developed in each fraction was
measured by densitometry. Values from each column run were normalized and
displaced by 0.3 units so that they could all be plotted on the same graph.
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Figure 3.7. GcboxT18-Sepharose yields more Sp1 than Gcbox and
(Gcbox)n-Sepharose.
Peak fractions from each of the columns showing Sp1 in Fig 4 were
pooled and two-fold serial dilutions were made. 600 µl of each dilution was
blotted on nitrocellulose paper and probed with anti Sp1 (PEP 2) antibody.
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could block the binding site for Sp1 and decrease yield. Alternatively, the
protracted procedure for preparing concatemers may have rendered some of the
DNA inactive. We did not find any significant difference in the purity of Sp1
obtained from the three columns (data not shown) and hence there is no distinct
advantage of using concatemeric columns for the purification of Sp1.
This comparison of transcription factor chromatography has resulted in
some important conclusions. The length and complexity of the DNA attached to
the columns affects their retention of transcription factors. As the length and
complexity of the DNA is increased, retention time increases for all three
transcription factors tested. The magnitude of the effect though is quite individual
for each protein. Retention of C/EBP is shifted only slightly as column attached
DNA is changed from an 18-mer to a concatemer five times as long (Figure 3.2).
Contrasted to this is the case of lac repressor, which shows dramatic changes in
retention (and resolution of proteolyzed repressors forms) as the Op1 25-mer is
extended by only an additional 18 bases with a T18 tail. Further lengthening to a
100-mer concatemer increases retention a little more (Figure 3.3). Of these two
types, Sp1 falls in the first group since it elutes from simple and complex columns
with quite similar retention times (Figure 3.6). This comparison suggests that
using two columns that differ in DNA complexity would be a prudent strategy for
resolving difficult mixtures of DNA-binding proteins. Since the largest effect of
complexity occurred with a modest increase in length, simply extending DNA with
a T18 tail or not would be a good choice for these two columns.
This individual effect of DNA complexity on each protein makes resolution

72

of complex mixtures by affinity chromatography alone more likely. This is seen in
Figure 3.4, Table 3.2, and in Figure 3.5. The contaminants found in C/EBP
depends upon the column used (Figure 3.4). This results from this individual
behavior. As column DNA becomes more complex, some proteins elute later
while others are little affected. The protein of interest may be sensitive or
insensitive to complexity, but in either case, the group of co-eluting (contaminant)
proteins will differ on different DNA columns (Figure 3.4) and purity may be
improved by altering the column DNA sequence (Table 3.2). This was shown
most dramatically by investigating two proteins which bound to the same column
(Figure 3.5). What happened was that on simple DNA columns these two
proteins (C/EBP and lac repressor) co-elute. Increasing DNA complexity moved
lac repressor to later retention times while C/EBP was still eluting early. This
increased the likelihood the two could be resolved. This models what happens
during purification: DNA columns bind multiple proteins that are resolved when
their retention times or peak widths are altered favorably.
The resolution of chromatography is improved as the stationary phase
support is made more homogeneous. Supports with uniformly coupled short DNA
sequences would be the most homogeneous. As DNA is made more complex,
either by chemical synthesis or ligation, the DNA is made more heterogeneous,
because neither synthesis nor ligation is 100% efficient. There is also the
potential that either could result in less of the DNA being active, another form of
heterogeneity which also affects column capacity. Inefficient chemical synthesis
results in differing lengths and some “footprint” binding regions being defective.
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Ligation can result in circular DNAs and, by crowding footprints together on a
DNA strand, steric crowding may make some inaccessible. Ligation also makes
DNAs of very different lengths, which represents a major form of heterogeneity.
The predicted outcome of such heterogeneity is seen in the data here. The more
complex DNAs give somewhat broader peaks, which probably results directly
from stationary phase heterogeneity (Figure 3.2, 3.2, and 3.4).
Chromatographically inactive DNA is probably the cause of the decreased yield
demonstrated in Table 3.2 and Figure 3.7. Thus, while DNA complexity can aid in
purification, it has the harmful consequence of sometimes increasing peak width
and decreasing column capacity.
The origin of concatemere DNA-affinity chromatography is the purification
of Sp1, where concatemers mimic the repetitive GCbox of the early promoter of
SV40 (21). However, our studies suggest that a non-concatemer column with a
GCbox made more complex with a T18 tail should actually work as well or better.
An unpublished study also showed that Sp1 binds to a non-concatemer column.
The promoter of TFIIIA contains three elements (E1, E2, and E3), which bind
transcription factors regulating TFIIIA expression in Xenopus oocytes. The
proteins which bind these elements were tentatively named B1, B2, and B3 (99).
E2 DNA was produced with a T18 tail coupled to Sepharose and this DNASepharose was successfully used to purify B2. The purified protein turned out to
be the Xenopus homolog of Sp1 (unpublished data, W.L. Taylor and W.T.
Penberthy). Since the identity of B2 wasn’t previously known, it is clear from
these results that Sp1 not only binds tailed, discrete sequences but that this
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binding is sufficiently specific to allow purification.
Furthermore, transcription factors and other DNA-binding proteins have
been purified by others using discrete DNA-Sepharose without apparent difficulty
(100) (101) (102) (103). Such discrete oligonucleotides are also effectively used
in most electrophoretic mobility shift assays (104) (including Sp1, (21)) and in
filter binding assays (89). Indeed, it is clear that transcription factors bind discrete
DNA sequences very well, with high affinity and specificity. Since simple, discrete
DNA sequences are sufficient for binding in all these cases, it is unlikely that
chromatography alone would require concatemers.
All these results suggest that there is no clear advantage to concatemeric
columns. For certain protein including C/EBP, columns made with just the
discrete DNA element give protein with high purity and yield. For other proteins
such as lac repressor which do not bind as well to discrete elements, columns
having a footprint region extended with a simple sequence like T18: A18 work
better than concatemeric column.
Making concatemeric columns involves more work and resources.
Sometimes it is hard to get the ligation to work in the first step and ligation has to
be repeated several times (78). This is not only time consuming but also leads to
loss of oligonucleotides during each step. Our study shows concatemeric
columns don’t have any distinct advantage for the three different transcription
factors we studied including Sp1, the original justification for the concatemeric
approach. Hence columns having just the footprint region or footprint region
extended with a simple DNA sequence would be more suitable for the purification

75

of transcription factors.
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Chapter: 4. Heparin elution of transcription factors from
DNA-Sepharose columns

Part of this chapter was published in Journal of Chromatography (1999)
848: 131-8. Permission was obtained from the publisher to use our published
article in the dissertation. Some variations in format were adapted for
thedissertation.
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4.1. Introduction
DNA-binding proteins such as transcription factors, DNA and RNA
polymerases and exo- and endonucleases play important roles in cellular
function, differentiation and regulation. Hence, purification and characterization of
these proteins is of great importance. The low amount of these proteins which
frequently occur in cells makes their purification challenging. DNA affinity
chromatography has been widely used for purification of DNA-binding proteins
(78) (77) (105). Specific or nonspecific DNA sequences are coupled to solid
supports such as silica, Sepharose or cellulose. The different coupling
procedures and supports have been previously reviewed (76) (78). After loading
of proteins on these columns, the proteins are usually eluted with a salt gradient
(76) (78). While DNA affinity chromatography is the most selective method
currently available for the purification of these proteins, only rarely is a
homogeneous transcription factor obtained using this method alone.
Heparin-Sepharose chromatography has also been widely used for
purification of a large number of different proteins, including DNA-binding
proteins (106) (107). For the latter proteins, the polyanionic structure of heparin
presumably mimics the highly negatively charged backbone of DNA giving
heparin the ability to bind the DNA-binding domains of protein (108). Conversely,
some DNA sequences are known to bind the heparin-binding motif in thrombin
(109). Heparin is typically coupled to Sepharose by cyanogen bromide activation
(110) and a salt gradient is usually employed to elute proteins from heparin
columns. Elution of proteins from heparin-Sepharose with heparin has also been
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reported (111). Since heparin-Sepharose is also used in the purification of many
other types of proteins, other protein types often co-eluted with DNA-binding
proteins, affecting purity.
Of all the methods which can be used for purification of DNA-binding
proteins, specific sequence DNA affinity chromatography offers the highest
selectivity. In spite of this high selectivity, purification to homogeneity is seldom
obtained with this technique alone. The specificity of DNA affinity
chromatography could be better exploited by using it repetitively (78). However,
repeating chromatography using the same or similar protocols would be of little
use. What is needed is to elute the highly selective columns each time using
different strategies based upon different principles. In practice, eluting protein
from DNA affinity columns is currently limited to using high salt and, for a few
proteins, elution by specific ligand; e.g., lac repressor elution with isopropyl β-Dthiogalactopyranoside (IPTG), or other lactose analogs. This limits the number of
times that DNA affinity chromatography can be effectively used in protein
purification protocols. Hence new elution methods, based upon different
principles, should facilitate their purification.
Lac repressor, which regulates the lac operon in E. coli (112) and CAAT
enhancer binding protein C/EBP (10) which binds the CAAT element in
eukaryotic promoters, are both well-characterized transcription factors. The DNA
sequences, which are specifically bound by these proteins, have been identified
(96) (66) In this paper we have used a lac repressor-β-galactosidase fusion
protein (laciz ) and a Green Fluorescent Protein-CAAT enhancer binding protein
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(GFP-C/EBP) fusion protein to characterize a new method for eluting DNAbinding proteins. Both laciz (84) (97) and GFP-C/EBP (98) have DNA-binding
properties comparable to lac repressor and C/EBP which justifies their use in our
model study. Here, we show that these proteins elute from DNA columns with
heparin in a highly purified state.

4.2. Methods

4.2.1 DNA Sepharose preparation
For studies with laciz, Op1T6 oligonucleotide (5'-NH2-(T) 6AATTGTTATCCGCTCACAATTCCAC), containing the operator 1 (Op1) DNA
sequence, was coupled to CNBr activated Sepharose. For studies with GFPC/EBP, EP18 (5'-NH2-GCAGATTGCGCAATCTGC) was coupled. The “5’-NH2“
represents the aminoethyl group added on the last synthesis cycle with the
Amino Link reagent (Applied Biosystems). Op1T6- and EP18- Sepharose were
prepared as described previously (74). Two grams of Sepharose 4B was washed
thoroughly with water. 0.4 g of cyanogen bromide was added while stirring and
the mixture was maintained at pH 11 by addition of 5 M NaOH until the reaction
slowed. The activated Sepharose was then washed rapidly under vacuum on a
coarse sintered glass funnel with 100 ml ice-cold water and then with 200ml icecold coupling buffer (100 mM NaHCO3, pH 8, 500mM NaCl). The Sepharose as
then mixed with 100 nmol of 5’-amino OP1T6 or 5’-NH2- EP18 to a final volume of
5 ml coupling buffer and mixed on a tube rotator overnight. The next day the
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DNA-Sepharose was washed with 15ml 100 mM NaHCO3 pH 8, 500mM NaCl.
The amount of DNA coupled, 22 nmol αOP1T6 and 29 nmol EP18 per gram of
Sepharose were determined by UV absorption spectroscopy of the DNA before,
and recovered after, coupling. The DNA-Sepharose was end-capped by adding
4ml of blocking buffer (100 mM Tris, 500 mM NaCl, pH 8) and incubating on a
tube rotator for 2 hours at 4°C. After incubation, the Sepharose was washed 2
times with 4 ml of TE0.1 buffer (10 mM Tris, pH 7.5, 1 mM EDTA, 0.1 M NaCl).
Op1T6 was made double stranded by adding 50 nmol of complementary strand
(5’GTGGAATTGTGAGCGGATAACAATTAAAAAA), the mixture was heated to
95°C, and allowed to cool slowly to room temperature. We refer to this doublestranded product here as Op1T6-Sepharose. The EP18 oligonucleotide is selfcomplementary and a double-stranded column results directly from coupling. All
columns were stored at 4°C in TE0.1 buffer containing 50 mM NaN3 when not in
use. The DNA concentration for different columns of Op1-Sepharose was
adjusted by diluting DNA-Sepharose with CNBr activated, and end-capped
Sepharose, which had beeen treated the same way except no DNA was used.

4.2.2 Production of proteins
Lac repressor-β-galactosidase fusion protein was produced by growing
clone BMH-72-19-1 which was the generous gift of Dr. David Levens (Laboratory
of Pathology, National Cancer Institute, Bethesda, Maryland). The clones were
grown overnight in 2 L. Superbroth (1.2% Bactotryptone, 2.4% Yeast extract,
0.5% glycerol, 0.072M K2HPO4 and 0.028M KH2PO4) at 37°C and then induced
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for 4 hours with 1 mM IPTG. The cells were pelleted by centrifugation at 8000
rpm for 30 min in the Sorvall GS-3 rotor The pelleted cells were resuspended in
40 ml lysis buffer (4 mg/ml lysozyme (Boehringer Mannheim, Indianapolis, IN,
USA, ), 5 mM NaH2PO4, 20 mM, Na2HPO4, 30 mM NaCl, 25 mM benzamidine,
10 mM 2-mercaptoethanol, 10 mM EDTA, 1 mM PMSF and 0.2% Tween20). The
cells were then lysed by sonication on ice for 30 sec, followed by 30 sec
incubation on ice without sonication; this was repeated 3 times at setting 12
using VirSonic50 sonicator with a microprobe.(Gardiner, NY, USA ). Cellular
debris was removed by centrifugation at 15,000 rpm for 30 min in the Sorvall SS34 rotor. The protein was dialyzed against TE0.1 buffer and stored at -85°C until
needed.
GFP-C/EBP was produced by growing E. coli strain BL21 containing
plasmid pJ22-GFPC/EBP as described previously (98).

4.2.3 Chromatography
All columns were 1 ml bed volume syringe columns initially equilibrated in
TE0.1 buffer. Crude preparations of either laciz or GFP-C/EBP was loaded onto
the column and eluted with a gradient of NaCl, heparin or IPTG. Details of the
gradient are given in the figure legends.

4.2.4 Assay of fusion proteins
GFP-C/EBP was assayed by measuring fluorescence as described earlier
(98) Laciz was assayed for β-galactosidase activity by mixing 150 µl of Buffer O
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(3 mM o-nitrophenyl-β-D-galactopyranosidase, 0.1 M NaH2PO4, 1 mM MgCl2
and 45 mM mercaptoethanol) with 50 µl of each fraction to be assayed. The
reaction was done on microtiter plates and monitored continuously at 25°C for
absorption at 405 nm.

4.2.5 Definition of enzyme units
One unit of laciz fusion protein was defined as that which gives a change
in 1 absorption unit (at 405 nm) per min per ml of enzyme at 25°C.

4.2.6 Protein assay
Protein concentrations were determined by bicinchoninic acid method
using the protocol provided by Pierce Chemical Co. All samples were
precipitated with 10% ice-cold TCA and redissolved in 2% Na2CO3, 0.1 M NaOH
before assay.

4.2.7 Polyacrylamide gel electrophoresis
Peak fractions from each column run were used for gel electrophoresis.
Sodium dodecylsulfate polyacrylamide gel electrophoresis was carried out on
12% gels using the method of Laemmli (87) and stained with silver after
electrophoresis using the kit provided by the Bio-Rad Laboratory (Richmond, CA
USA).
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4.3. Results
Figure 4.1 shows that GFP-C/EBP can be eluted from EP18 DNA-column
with either a salt or heparin gradient. It was shown earlier that GFP alone does
not bind to the DNA Sepharose column (98). The fusion protein does not bind to
Sepharose with no coupled DNA (data not shown). This indicates that the binding
of this fusion protein to the column was due to the specific interaction between
C/EBP and the specific DNA sequence coupled to the column, an interaction
disrupted by high salt or heparin concentrations.
Since this is the first demonstration of heparin elution in DNA affinity
chromatography, we next investigated whether other transcription factors can be
eluted in the same way.
The elution of laciz from the Op1T6-Sepharose column is shown in Figure
4.2. The amount of laciz eluted is dependent on the concentration of heparin in
the mobile phase; however, concentrations of more than 40 mg/ml have a high
viscosity and were not used routinely. A negative control, β-galactosidase, does
not bind to the DNA-Sepharose column. Laciz also failed to bind to the column
containing only Sepharose indicating the specific interaction between laciz and
lac operator sequence bound to the column provides the basis for this
chromatography as well. Thus, elution is dependent upon the heparin
concentration of the mobile phase.
Figure 4.1 and 4.2 also show considerable material flowing through the
column unretained. The columns in these experiments were intentionally
overloaded so that we could gauge the ability of salt or heparin to elute all of the
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Figure 4.1. Elution of GFP-C/EBP with heparin from EP18-Sepharose.
A crude bacterial extract (500 µl) containing GFP-C/EBP was loaded on a
1 ml EP18-Sepharose column having 29 nmol DNA/g of resin. The column was
washed with 16 ml TE0.1 and was eluted either with a 20 ml heparin gradient
from 0-40 mg/ml heparin dissolved in TE0.1 or with a 20 ml salt gradient from
TE0.1 to TE1.2 (10 mM Tris, pH 7.5, 1 mM EDTA, 1.2 M NaCl). The flow rate
was 0.5 ml/min and 1 ml fractions were collected.
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Figure 4.2. Effect of heparin concentration on elution of laciz from Op1T6Sepharose.
Bacterial extract (100 µl) containing laciz was loaded onto a 1 ml Op1T6Sepharose column having 4.4 nmol DNA/g of support. The column was washed
with 10 ml of TE0.1 and eluted with either 1 mg/ml, 10 mg/ml or 40 mg/ml
heparin dissolved in TE0.1. The flow rate was 0.5 ml/min min and 1 ml fractions
were collected and assayed.
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retained protein and to obtain large peaks which clearly show where elution
occurred. However, the size of the unretained peak is also unrepresentative of
the amount of the transcription factor which did not bind and overestimates it.
Crude bacterial extracts contain multiple fluorescent compounds (Figure 4.1) and
glycosidases (Figure 4.2; e.g., β-galactosidase) which are also present in these
unretained fractions and increase the signal obtained. When these fractions are
analyzed by sodium dodecylsulfate – acrylamide gel electrophoresis and other
methods (data not shown), we find that most of the DNA-binding protein binds to
the column and is then eluted by either salt or heparin. After washing away these
contaminants, the signal (fluorescence or enzymatic activity) of the eluted peak
does accurately reflect the amount of the fusion protein eluted.
Figure 4.3 shows that more laciz elutes with 10 mg/ml heparin from
columns having lower amounts of DNA. Columns with lesser amounts of DNA
coupled also bound slightly less of the applied protein and yet, even though less
bound, more total laciz is obtained from the 4.4 nmol column elution. This is
because even though more laciz binds to high DNA columns, most of it cannot
be eluted by the fixed, 10 mg/ml heparin concentration used in the figure. Higher
concentrations of heparin or salt would be required for complete elution.
While laciz has its highest affinity for its specific operator sequence, the
lac repressor (and many other transcription factors) will also bind to non-specific
DNA sequences, albeit with lower affinity. Figure 4.4 shows that laciz binds to
EP18-Sepharose, a non-specific DNA in this context, and elutes with heparin.
The EP18 sequence is not a normal consensus operator sequence for
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Figure 4.3. The effect of DNA concentration on elution of laciz from
Op1T6-Sepharose.
Crude bacterial extract (100 µl) containing laciz was loaded onto 1 ml
Op1T6-Sepharose columns having either 4.4 nmol, 11 nmol or 22 nmol DNA/g of
Sepharose prepared by mixing 22 nmol/g DNA-Sepharose with control
Sepharose. The columns were washed with 10ml of TE0.1 and eluted with
10mg/mL heparin dissolved in TE0.1. The flow rate was 0.5 ml/min min and 1 ml
fractions were collected
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Figure 4.4. Elution of laciz from the EP18 column.
Crude bacterial extract (500 µl) containing laciz was loaded onto the
EP18-Sepharose column having 29 nmol DNA/g of resin. The column was
washed with 15 ml of TE0.1 and was eluted with a 20 ml heparin gradient from 040mg/ml heparin in TE0.1. Any uneluted protein was then eluted with 5 ml of
TE1.2. The flow rate was 0.5 ml/min min and 1 ml fractions were collected.
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the lac repressor; the two sequences only have the CAAT element in common
between EP18 and Op1 DNA. However, large amounts of laciz bind to the EP18Sepharose column (Figure 4.4). A negative control, β-galactosidase does not
bind to EP18-Sepharose (data not included).
Figure 4.4 demonstrates that most of the bound protein is eluted by
heparin and very little additional laciz can be eluted with high salt. This EP18
column contains a relatively high amount of DNA (29 nmol/g Sepharose) and yet
heparin elutes it completely. Even when lesser amount of a specific DNA were
used in Figure 4.3, complete elution was not obtained at these heparin
concentrations. Thus, the specificity of the DNA-sequence used for the stationary
phase also influences the heparin concentration required for elution. Thus, with
two different transcription factors and with two different DNA-Sepharose
columns, heparin is an effective eluent and elutes proteins which are specifically
as well as nonspecifically bound. Heparin-elution is probably a general
phenomenon which is widely applicable.
The purity and yield of protein obtained from the different elution methods
is compared in Table 4.1. We found that the heparin pool was very pure as
compared to the salt pool. The fold purification of the heparin pool was
significantly greater than the salt pool with P= 0.014 (i.e., significantly different at
the 1% confidence level). The lower yields obtained for both heparin and salt
were because of loading a large excess of protein onto the small columns so that
sufficient protein eluted to determine its amount accurately.
We couldn’t directly compare ligand specific elution using IPTG under the
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Table 4.1. Heparin eluted laciz is significantly purer than that eluted
with salt.

Fraction

Total Enzyme, U.

Total protein, mg

Yield

Fold Purification

Crude

4.5

10.3

100

1

Heparin

0.56

0.006

10 ± 6

212 ± 84

Salt

0.87

0.040

16 ± 9

48 ± 11

a

The results of three experiments were averaged (n=3) and averages are

reported for all columns and with standard deviations for yield and purification.
For each experiment, 2ml of a bacterial extract containing laciz was loaded onto
a 1 ml. Op1T6-Sepharose column having 11nmol DNA/g of Sepharose. The
column was washed with 10 ml of TE0.1 and then eluted either with a 20 ml
heparin gradient from 0-40mg/ml heparin in TE0.1 or with a 20 ml salt gradient
from TE0.1 toTE1.2 (10 mM Tris, pH 7.5, 1 mM EDTA, 1.2 M NaCl). The flow
rate was 0.5 ml/min. Active fractions were pooled together for assay.
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same conditions used in Table 4.1 because very high concentration of IPTG
were required for elution in the TE0.1 buffer and these concentrations interfered
with the β-galactosidase assay, giving erroneous results. Dialysis to remove the
IPTG was also unsuccessful since dialyzing the laciz protein at these high
dilutions led to its inactivation. It was found that less IPTG is required for elution
when the NaCl concentration of the mobile phase is increased to 0.3 M and βgalactosidase activity could be accurately measured in the presence of these
lower IPTG concentrations (data not shown). Under these conditions the purity of
protein eluted with IPTG was also greater than that of salt eluted protein (Table
4.2). However, when heparin elution was attempted at 0.3 M NaCl so little protein
eluted that, despite concentrating the eluate and trying two different sensitive
protein assays, it was not possible to get an accurate measure of protein
concentration and, hence, the purity of the heparin eluted fraction. Thus, while
heparin and IPTG could not be compared directly under the same conditions, the
indirect comparison shown in Tables 4.1 and 4.2, show that IPTG elution yields
purity which is similar to that obtained with heparin, and that any difference is not
likely to be statistically significant.
Comparison of Tables 4.1 and 4.2 also demonstrates another important
point – the purity of salt-eluted protein can be greatly improved by washing the
column at an intermediate salt concentration. In Table 4.1, when the column was
washed with TE0.1 prior to elution, the protein is only 1/3 as pure as in Table 4.2
where washing in TE0.3 was performed. Washing with higher salt removes
additional contaminants.
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Table 4.2. Comparison of heparin and IPTG eluted Laciz.

Fraction

Total Enzyme U

Total protein, mg

Yield

Fold Purification

Crude

2

2.7

100

1

IPTG

0.53

0.0025

24 ± 11

254 ± 38

Salt

0.67

0.007

35 ± 5

148 ± 66

a

The results of the two experiments were averaged (n=2) and averages

are reported for all columns and with standard deviations for yield and
purification. For each experiment, 500 µl bacterial extract of laciz was loaded on
1ml OP1T6 having 11nmol DNA/g of Sepharose. The column was washed with
10 ml of TE0.3 (10mMTris, pH 7.5, 1mM EDTA, 0.3 M NaCl ) and eluted with 20
ml gradient of IPTG 0-0.1M in TE0.3 or with a 20 ml salt gradient from TE0.1 to
TE1.2. The flow rate was 0.5 ml/min. All the active fractions were pooled together
for assay.
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Figure 4.5 shows the gel electrophoresis of IPTG, salt and heparin eluted
fractions of laciz. It can be seen that the salt eluted fraction (in this case, from the
column washed only with TE0.1) contains some contaminant proteins along with
laciz fusion protein. However, the heparin fraction is very pure and only a single
band corresponding to the laciz fusion protein (Mr 155 kDa.) is seen. As
expected the IPTG fraction is also very pure.

4.4. Discussion
We have described an alternative method of eluting proteins from
sequence specific DNA Sepharose columns. We have shown that GFP-C/EBP, a
member of basic leucine zipper DNA-binding motif family of proteins (66) and
laciz, having a helix-turn-helix motif (13) can both be eluted with heparin. It is
very likely that protein having other DNA-binding motifs will also elute with
heparin. We have also shown that protein (laciz) which is bound to a non specific
sequence (EP18) can also be eluted with heparin (Figure 4.4). Our hypothesis is
that the elution with heparin results from a direct competition between heparin
and DNA for the same site on the protein. During elution a dynamic equilibrium is
established in which the protein shuttles between heparin in the mobile phase
and DNA which is bound to the column. This equilibrium is affected by the
concentration of DNA bound to the column, the amount of heparin in the mobile
phase, and the affinity of protein for both DNA and heparin. Elution with salt, on
the other hand, presumably results from salt shielding the charge on DNA and
protein and hence disrupting ionic interactions between them. Ligand specific
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Figure 4.5. Polyacrylamide gel of the salt-, IPTG- and heparin-eluted
protein.
Lanes 1, 2 and 3 represent heparin, salt, and IPTG eluted fractions,
respectively. Lanes 1 and 2 are from the same gel; lane 3 was taken from a
second gel and is shown for comparison.
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elution of lac repressor is caused by the ligand (IPTG) binding to a site other than
the DNA-binding site leading to a conformational change and diminished DNAbinding properties. Thus elution with heparin is not just a new but probably a
mechanistically different type of elution than either salt or ligand based elution.
Our hypothesis about competitive elution is supported since elution of
laciz from the column is dependent upon the concentration of both column DNA
and mobile phase heparin. This competitive elution probably accounts for the
purer protein eluted by heparin relative to that obtained with salt. IPTG elution
also yields highly purified protein but very few transcription factors have a
specific ligand with which to elute them. In any case, our data suggest that
heparin eluted protein is comparable in purity to IPTG eluted protein and purer
than obtained with salt under the same conditions, the most commonly used
strategy to elute transcription factors from DNA columns. Protein eluted with
heparin can be diluted and reapplied to the same DNA column (data not shown)
allowing repetitive uses of same DNA column with different elution strategies.
Another interesting observation was that when heparin was dissolved in TE
containing 0.3M NaCl (TE0.3), the laciz activity eluted as a broader peak which
contained so little protein it could not be accurately measured even after
concentrating the protein and using sensitive protein assay techniques. This low
protein concentration is also indicative of high purity but the purity could not be
accurately measured. High salt concentrations have been shown to decrease the
affinity of lac repressor for DNA (113) and we suspect high salt also decreases
the affinity of this transcription factor for heparin. As both affinities are decreased,
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a broad peak results.
Heparin represents a very flexible and controllable method for eluting
transcription factors from DNA columns. Elution is affected by the heparin and
salt concentration of the mobile phase (Figure 4.1 and 4.2, Table 4.1), the
amount of DNA on the stationary phase (Figure 4.3 a and b), and its sequence
(Figure 4.4). The purification obtainable is several hundred-fold and comparable
to that obtainable when ligand-specific elution is feasible. In contrast, salt
dependent elution is a much less flexible, cruder strategy. However, by washing
columns at an intermediate salt concentration prior to elution, the method can be
improved. By optimizing both salt and heparin elution of a particular protein, high
purity of DNA-binding proteins should be more easily achieved.
A possible drawback of using heparin to elute was the lower yields
obtained but this can be easily overcome by controlling the amount of DNA
bound to the column. Another strategy to increase yield is to decrease the affinity
of the column bound DNA sequence for the protein. This can be achieved by
altering crucial base pairs of the DNA sequence or by using a nonspecific, or less
specific, column. We have shown that laciz binds to EP18 column, a rather
extreme case of an “altered DNA”, and can be eluted with heparin. It was also
observed that almost 90% of bound protein was eluted with heparin from this
column while about 50% of bound protein is eluted from the specific Op1T6
column under similar conditions and when the columns have comparable amount
of DNA (data not included).
In a previous paper our laboratory has discussed temperature-dependent
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elution of transcription factors (98). In this paper we have demonstrated heparin
as specific eluent of two different transcription factors. DNA affinity
chromatography is the most selective of any known method for the purification of
transcription factors. Alternative methods for eluting proteins from DNA columns
such as temperature-dependent elution and heparin elution, allow this high
selectivity to be applied repetitively to aid in the purification of DNA-binding
proteins.
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Chapter: 5. Bi-column method for purification of
transcription factors

Part of this chapter was published in Journal of Chromatography (2001)
905: 133-9. Permission was obtained from the publisher to use our published
article in the dissertation. Some variations in format were adapted for
thedissertation.
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5.1. Introduction
Purification and characterization of transcription factors and other DNA
binding proteins such as DNA polymerases, and endo- and exonuclease is
important. These proteins control important cellular processes such as regulating
the transcription of genes, DNA replication, recombination, cell division and
differentiation. Moreover these proteins are frequently present in cells in small
amounts and hence their purification is challenging.
A typical purification for transcription factor such as Sp1 involved
purification through five steps (21) the last being DNA affinity chromatography.
All these required steps make this purification time consuming. Furthermore,
since no purification step yields complete recovery, the overall yield is often low.
DNA affinity chromatography offers the highest selectivity and hence is widely
used for purification of DNA binding proteins. Improvements in DNA affinity
chromatography could allow purification in a lesser number of steps and
significantly reduce the effort required.
DNA affinity columns are made by attaching either nonspecific (100) or
specific (74) DNA sequences to a variety of supports such as cellulose, agarose,
silica, etc. and has been discussed in more details elsewhere (76) (78). Nonspecific DNA (e.g. salmon sperm or other fragmented genomic DNA) selects only
for the property of DNA binding and hence nonspecific DNA columns are not
selective for a particular protein. Specific columns on the other hand are highly
selective and are made by coupling carefully designed sequences, which are
specifically bound by the protein of interest. Although specific columns are highly
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selective, more than one protein can often bind to these columns and
contaminate the protein of interest.
Several approaches to improving the purity obtained have been reported.
These include repeated use of DNA affinity columns (114), using nonspecific and
specific sequence DNA affinity columns in tandem (115), using multimeric
(concatemeric) DNA columns (77), washing the columns with a nonspecific DNA
sequence, or pre-incubating extracts with nonspecific DNA sequences (21) (78).
In spite of these efforts, homogenous protein is rarely obtained with DNA affinity
chromatography as the only step and clearly new approaches are needed. We
have previously shown that DNA binding proteins such as lac repressor and
CAAT enhancer binding protein (C/EBP) can be eluted from DNA affinity
columns by using heparin. Elution results from competition between the anionic
polysaccharides (heparin and DNA) for transcription factor binding (60) and
represents a novel elution method.
Lac repressor protein, which regulates the lac operon in Escherchia coli,
has been studied extensively. A DNA operator sequence (Op1) which is bound
by this protein has been identified (96). We have shown previously (75) that lac
repressor binds more tightly to columns having Op1 with an additional (dA)18:
(dT)18 tail than to columns having Op1 alone. Two other transcription factors
have also been investigated. C/EBP binds to CAAT elements in some eukaryotic
and viral promoters and regulates gene expression (22) (66). B3 is a
developmentally regulated transcription factor, which regulates TFIIIA
transcription in early stage oocytes (99).
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In this paper we describe a new method which we call the Bi-column
method for purification of transcription factors. This method involves the use of
two columns having high specificity but different affinities for the transcription
factor of interest. Proteins such as lac repressor-β-galactosidase fusion protein
(laciz), are eluted with heparin from a column having high specificity but
moderate affinity (Op1-Sepharose). The eluate is passed over a second column,
connected in tandem, having both high specificity and higher affinity. The
proteins that are bound by the second column are finally eluted with salt. While
we developed this method originally as a fascile way to remove heparin from
samples, the method has advantages for purification we did not anticipate. We
have shown that this approach gives highly pure lac repressor, C/EBP and B3
proteins.

5.2. Methods

5.2.1 DNA Sepharose preparation
The oligonuucleotides shown in Table 5.1 were used for coupling to
Sepharose. All strands having Aminolink were coupled to CNBr-preactivated
Sepharose 4B (Sigma, St. Louis, MO, USA). Coupling and end-capping were
carried out according to the protocol provided by the manufacturer. The columns
were made double stranded by adding the corresponding complementary strand.
The mixture was then heated to 95°C and allowed to cool slowly to room
temperature. (EP18)5 is self complementary and does not require the addition of
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Table 5.1. Oligonucleotides used in for coupling to Sepharose.

Name

Sequence of strand which was coupled

Sequence of complementary
strand

Op1

5'-NH2-

5’GTGGAATTGTGAGCGGATAA

AATTGTTATCCGCTCACAATTCCAC

CAATT

5'-NH2-(T) 18-

5’GTGGAATTGTGAGCGGATAA

AATTGTTATCCGCTCACAATTCCAC

CAATTA18

(EP18)5

5'-NH2-(GCAGATTGCGCAATCTGC)5

NA*

(EP9)10

5'-NH2-(GCAGATTGC)10

(5’GCAATCTGC)10

E3

5’-NH2-

5’-

TGTGGTTACTAGGTTACAAATTACCC

CATGGTTGCTAGGGTAATTTGT

TAGCAACCATG

AACCTAGTAACCACA

5’-NH2-

5’-

AAATTACCCTAGCAACCATGCATT

AATGCATGGTTGCTAGGGTAA

Op1T18

E3/2

TTT

* NA stand for not applicable, EP18 and (EP18)5 are self complementary
and do not require the addition of a second strand.
“5’NH2“ represents aminoethyl group added on the last synthetic cycle
with the Aminolink reagent (Applied Biosystems)
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a complementary strand. The amount of DNA coupled was determined by the
difference in UV absorption of DNA added and recovered after coupling. 115 µg
of (EP18)5, 95 µg of (EP9)10 ,177 µg of Op1, 160 µg of Op1T18, 230 µg of E3/2
and 253 µg of E3 was found to be coupled /g Sepharose.

5.2.2 Production of proteins
Lac repressor-β-galactosidase (laciz) fusion protein was produced as
described earlier (60) by growing clone BMH-72-19-1 which was generous gift of
Dr. David Levens (Laboratory of Pathology, National Cancer Institute, Bethesda,
Maryland).
TB1 cell extract was obtained by using the same protocol used for
production of laciz the only difference was that E. coli strain TB1 containing
plasmid pMalC (New England Biolabs, Beverly, MA, USA) was used in place of
clone BMH-72-19-1.
Rat liver nuclear extract used for studies on C/EBP was prepared by the
procedure described in (116).
Xenopus laevis oocyte extract used for B3 purification was made from
stage I-II Xenopus oocytes as described in (99)

5.2.3 Chromatography
All supports were packed in 1 ml bed volume syringe columns initially
equilibrated in TE0.1 buffer (10 mM Tris, pH 7.5, 1 mM EDTA, 0.1 M NaCl).
Details of elution and the gradient used are given in the figure legends.
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5.2.4 Assay of laciz
Laciz was assayed for β-galactosidase activity by using the protocol
described previously (60) and in Chapter 3 of thisdissertation.

5.2.5 Polyacrylamide gel electrophoresis
All samples were concentrated using Centriplus centrifugal filter devices
supplied by Milipore Corporation (Bedford, USA). One fourth of each sample was
applied to sodium dodecylsulfate 12% polyacrylamide gels using the method of
Laemmli (87) and stained with silver using the Bio-Rad Laboratory kit (Richmond,
CA USA ).

5.2.6 Western blot analysis
Electrophoresis was carried out as above, proteins were then transferred
to nitrocellulose filters and probed with appropriate antibodies as described by
Towbin et al. (117). For lac repressor, a 1:5000 diluted rabbit anti-lac repressor
polyserum (Stratagene, La Jolla, CA, USA) was used as primary antibody. For
C/EBP a 1:5000 dilution of anti-C/EBP (14AA) supplied by Santa Cruz
Biotechnology (Santa Cruz, CA, USA) was used as primary antibody. A 1: 5000
dilution of rabbit polyserum generated against purified B3 (HTI Bioproducts) was
used as primary antibody for detection of B3. Immunoreactive proteins were
visualized by using a 1:3000 diluted rabbit secondary antibody alkaline
phosphatase conjugates and stained for alkaline phosphatase using a kit
supplied by Promega (Madison, WI USA).
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5.3. Results and discussion
Figure 5.1 shows elution of lac repressor-β-galactosidase (laciz) fusion
protein from Op1 and Op1T18 columns. It can be seen that laciz elutes from Op1
as a sharp peak at heparin concentration from 10-20 mg/ml with the peak fraction
at 16 mg/ml. The peak of laciz eluted from Op1T18 is fairly broad, with laciz
eluting at heparin concentrations as low as 10 mg/ml, however, the bulk of laciz
elutes at heparin concentrations between 25-40 mg/ml with the peak fraction at
32 mg/ml. These data are in agreement with our previous report where we had
shown a similar difference in the salt elution of this protein from these two
columns (75). The Op1T18 column shows some heterogeneity in the eluted peak.
We have found that some proteolysis occurs in the laciz protein. Since both βgalactosidase and lac repressor form tetramers, a large number of species could
be formed with truncated forms of laciz and this probably accounts for the
heterogeneity observed.
Figure 5.2 shows a diagrammatic presentation of the Bi-column method.
Column A in the figure represents a column such as Op1-Sepharose, which has
a moderate affinity for the protein to be purified. Because of the moderate affinity,
proteins elute from this column at a low heparin concentration. Column B
represents columns such as Op1T18, which have a greater affinity for the protein.
Although column A has a moderate affinity, it is by no means a nonspecific
column as it includes either the entire 25 base pair Op1 sequence bound by lac
repressor protein or a part of a known DNAse1 footprint (EP9 or E3/2) bound by
C/EBP and B3, respectively. Column B on the other hand has the entire footprint
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Figure 5.1. Elution of laciz from Op1-Sepharose and Op1T18-Sepharose
with heparin.
100 µl of crude bacterial extract containing laciz was loaded onto either
Op1-Sepharose or Op1T18-Sepharose, the columns were washed with 10 ml of
TE0.1(10 mM Tris, pH 7.5, 1 mM EDTA, 0.1 M NaCl) and eluted with a 20 ml
gradient of heparin from 0-40 mg/ml in TE0.1 followed by one more wash with 10
ml TE0.1. The flow rate was 0.5 ml/min and 1 ml fractions were collected.
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1
Load crude extract on column A and wash with 10 ml of TE0.1
A

2
Wash columns A&B with 20ml gradient of heparin from 025mg/ml inTE0.1.
A

B

3
Elute column B with TE1.2
B

Figure 5.2. Diagrammatic representation of Bi-column method.
Column A represents Op1, (EP9)10 or E3/2-Sepharose. Column B
represents Op1T18, (EP18)5 or E3-Sepharose. TE1.2 is 10 mM Tris, pH 7.5, 1 mM
EDTA, 1.2 M NaCl.
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region (EP18 and E3) and sometimes a footprint with additional sequences
attached to it (Op1T18) which increases binding affinity. Crude protein extract is
loaded onto column A which is washed with TE0.1. Column B is then attached
downstream of column A. A heparin gradient is applied to the Bi-column at
concentrations which will elute the protein from column A but not from column B.
Column B is then separated and eluted with buffer TE1.2 which contains 1.2 M
NaCl to obtain the purified transcription factor free of heparin.
Figure 5.3 shows such a Bi-column experiment for lac iz. Op1-Sepharose
and Op1T18-Sepharose are used as columns A and B, respectively. Most of the
laciz that is eluted from Op1 with heparin in step 2 is able to bind to the Op1T18
column and very little passes through the column as can be seen in fractions 2035 in Figure 5.3. Laciz then elutes as a sharp peak in fractions 40-45 from the
Op1T18-Sepharose column with TE1.2.
The Bi-column method also works with the lacIq mutant of the lac
repressor protein expressed from the low copy number pMalc plasmid. It can be
seen from Figure 5.4 that highly purified lac repressor protein is obtained with the
Bi-column method (lane1) when a crude bacterial extract is used as the starting
material. It can also be seen from the figure that protein obtained from the same
extract with salt elution alone of Op1T18-Sepharose is impure and many bands of
protein impurities can be seen on the gel (lane2). Lanes 3 and 4 show a western
blot with specific lac repressor antibody of the proteins in lanes 1 and 2.
Figure 5.5 shows a Bi-column purification of C/EBP from rat liver nuclear
extract. (EP9)10-Sepharose which has only half of the binding site for C/EBP was
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Figure 5.3. Bi-column elution of laciz.
300 µl of crude extract containing laciz was loaded onto Op1-Sepharose
and the Bi-column elution was carried out as described in Figure 5.2. Op1Sepharose was used as column A and Op1T18-Sepharose was used as column
B. The flow rate was 0.5ml/min and 1 ml fractions were collected.
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Figure 5.4. The Bi-column method works better for purification lac
repressor than salt elution.
500 µl of crude extract containing lacIq produced from a low copy number
plasmid was loaded onto Op1-Sepharose and the Bi-column elution was carried
out as in Figure 5.2 except a 10 ml wash with TE0.4 (10 mM Tris, pH 7.5, 1 mM
EDTA, 0.4 M NaCl) was applied to column B (Op1T18–Sepharose) before eluting
the protein with TE1.2. For salt elution, 500 µl of crude extract containing lac
repressor was loaded onto Op1T18-Sepharose, the column was washed with 30
ml TE0.1 followed by a 10 ml wash with TE0.4, and eluted with 10 ml TE1.2.
Lanes 1 and 2 are from a silver stained gel while lanes 3 and 4 are western blots
of Bi-column purified and salt eluted lac repressor, respectively.
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Figure 5.5. Bi-column method and salt elution purification of C/EBP.
500 µl of rat liver nuclear extract containing C/EBP was loaded onto
(EP9)10 –Sepharose and the Bi-column experiment was carried out as described
in Figure 5.2. (EP9)10 - and (EP18)5 –Sepharose were used as columns A and B,
respectively. A 10 ml wash with TE0.4 was applied to column B before eluting the
protein with TE1.2. For salt elution, 500 µl of Rat liver nuclear extract containing
C/EBP was loaded onto (EP18)5 –Sepharose. The column was washed with 30
ml TE0.1, followed by a 10 ml wash with TE0.4, and eluted with 10 ml TE1.2.
Lanes 1 and 2 represent a silver stained gel while lanes 3 and 4 are western
blots of C/EBP purified with Bi-column and salt elution, respectively.
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used as column A and (EP18)5-Sepharose which consists of 5 tandem copies of
the entire DNA binding sequence was used as column B. We found that Green
fluorescent protein-CAAT enhancer binding protein chimeric fusion protein (GFPC/EBP) binds to (EP9)10 but elutes at a lower heparin concentration than from
(EP18)5 (data not shown), hence these two columns were used. It can be seen
from the figure that the Bi-column method gives highly purified protein and only
two or three contaminant protein bands can be seen after silver staining (lane1).
Protein purified with single step salt elution on the other hand looks very impure
and several other contaminant protein bands can be seen along with that of
C/EBP on the gel (lane2). Lane 3 and 4 show western blots of the samples used
for lanes 1 and 2. Notice that so little C/EBP elutes with salt that it can be barely
detected with antibody while with Bi-column method, it is a major constituent.
Transcription factor B3 regulates TFIIIA transcription in early Xenopus oocytes.
The DNA binding region of B3 consists of four dyads. It has been reported earlier
(99) that B3 binds with a lower affinity to a sequence containing dyads 3 and 4
(E3/2) than to sequence containing all four dyads (E3). Hence we used E3/2Sepharose and E3-Sepharose as column A and column B in Bi-column method,
respectively. It can be seen from Figure 5.6 that the Bi-column method works
very well for purification of B3 from Xenopus oocyte extract and a single band of
B3 can be seen after silver staining (lane1). As for C/EBP and lac repressor,
conventional salt elution gives an impure protein and several other protein bands
are visible on the gel (lane 2). The western blot however confirms that salt elution
gives higher yield.

113

Figure 5.6. Bi-column and salt elution for purification of B3.
500 µl of Xenopus ocyte extract containing B3 transcription factor was
loaded onto E3/2 –Sepharose and the Bi-column experiment was carried out as
depicted in Figure 5.2. E3/2 -Sepharose and E3 –Sepharose were used as
columns A and B, respectively. A 10 ml wash with TE0.4 was applied to column
B (E3 –Sepharose) before eluting the protein with TE1.2. For salt elution, 500 µl
of Xenopus oocyte extract containing B3 was loaded onto E3–Sepharose, the
column was washed with 30 ml TE0.1, followed by a 10 ml wash with TE0.4, and
eluted with 10 ml TE1.2. Lanes 1 and 2 represent silver stained gel while lanes 3
and 4 are western blots of B3 purified with the Bi-column and salt elution,
respectively.
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We have shown earlier that laciz eluted with heparin from a Op1T6
columns is highly pure (60). Although heparin eluted protein is highly pure,
heparin has to be removed later since it can interfere with the DNA binding
activity of the protein. The Bi-column method was initially developed to remove
heparin. We found out that the Bi-column methods not only performs this function
but is also very effective way of purifying transcription factors.
Highly pure lac repressor, C/EBP and B3 can be obtained, from their
respective sources, bacterial extract, rat liver nuclear extract and Xenopus
oocyte extract by using the Bi-column method alone. The Bi-column method is
probably effective because it combines the use of two different specific DNA
affinity columns and two different elution methods. In the Bi-column method the
proteins shuttles from DNA on Column A to heparin in mobile phase and back to
DNA on column B. The protein to be purified has a higher affinity for column B
and hence can be retained by it. Proteins, which are nonspecifically bound to
column A on the other hand probably, have similar affinities for both columns and
hence are not retained by column B.

5.4. Conclusions
The Bi-column method could be extended to purify any transcription factor
as long as its DNA element has been, or can be, identified and two high
specificity columns having different affinities for the transcription factor can be
generated.
This Bi-column protocol yields higher purity of B3 that has ever been
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reported, even using much more complex purification schemes involving several
different chromatographic steps. The C/EBP obtained is also of a higher purity
than has ever been obtained from such a simple technique as the Bi-column
(62). These purifications are all from less than one ml of a crude extract
containing only native or near native amounts and yet could be purified to levels,
which would be sufficient for characterization.
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Chapter: 6. An oligonucleotide trapping method for the
purification of transcription factors
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6.1. Introduction
DNA affinity chromatography is one of the most widely used techniques
for the purification of transcription factors and other DNA binding proteins (100)
(77) (74). Either nonspecific or specific DNA affinity columns are used for these
purifications. Nonspecific columns were the first DNA affinity columns to be made
and were made by coupling diverse DNA sequences, such as fragment salmon
sperm genomic DNA to cellulose (67). Since then, there have been several new
advances in the technique. Highly specific columns made by using the footprint
region, the region of DNA that is protected from cleavage by DNAse1 upon
binding of a specific DNA binding protein, have replaced nonspecific columns for
transcription factor purifications for most applications. Various supports such as
Sepharose, cellulose and silica are routinely used for coupling of DNA and
several coupling chemistries are available for attaching DNA to these supports
(76). The most commonly used method is coupling of the amino groups either
inherently present in DNA or introduced during oligonucleotide synthesis to
cyanogen bromide-activated Sepharose (95).
Chemical coupling of the oligonucleotide can cause modifications of
nucleotides within the DNA sequence. Such modifications can potentially affect
the specific DNA-protein interaction, which in turn may lead to decreased
efficiency of the DNA affinity columns in protein purification. Modification of the
nucleotide bases can also lead to decreased capacity of the column for its
specific protein. There are only a few methods that allow the use of unmodified
DNA sequences. The enzymatic synthesis method (81) which was developed
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previously in our lab, involves synthesis of an unmodified DNA sequence on the
column by using the Klenow fragment of DNA polymerase. In the other method,
the highly specific biotin streptavidin interaction is used to trap a biotynilated
DNA-protein complex (72) (31). In this method a biotinylated oligonucleotide is
immobilized on a streptavidin containing support, which is then used for the
affinity chromatography of DNA binding proteins. Streptavidin coated magnetic
beads can be used as the support for coupling of biotinylated oligonucleotide as
they can be easily separated from solution with a strong magnet. In some cases
a biotinylated oligonucleotide is allowed to interact with proteins in solution and
the protein-DNA complex is then trapped onto a streptavidin containing support
(72) (118). In a third method, specific DNA affinity columns are made by
immobilizing a footprint region containing a 3’ polyA tail onto a polyT-agarose
column (119). These columns are then used to purify DNA binding proteins.
Other methods that allow coupling of unmodified DNA include oligonucleotide
synthesis directly on a Teflon fiber support (103) and coupling of
thiophosphorylated oligonucleotide to bromoacetyl agarose (120) but are not
routinely used for making DNA affinity columns.
Most of the methods mentioned above have certain disadvantages. The
enzymatic synthesis method can lead to tail length heterogeneity of the DNA.
The heterogeneity of these columns could potentially lead to peak broadening
and decreased purity. Comparative studies between enzymatically and
chemically synthesized columns have shown that there is no distinct advantage
in using enzymatic synthesis method for transcription factor purification (75). The
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streptavidin supports have a high affinity for biotinylated oligonucleotides but
such supports can also bind to several other proteins in the crude extract,
especially protein containing the biocytin group. Many proteins can bind to
streptavidin nonspecifically and elute during chromatography. These proteins can
potentially coelute with the protein of interest and decrease the purity. Newer
forms of streptavidin such as monomeric avidin and NeutrAvidin are supposed to
show lower nonspecific interactions.
We have used the green fluorescent protein CAAT enhancer binding
chimeric protein (GFP-C/EBP) to study a new method called the oligonucleotide
trapping method. CAAT enhancer binding protein (C/EBP) regulates expression
of several genes in mammals and certain viruses (121). C/EBP is one of the
most studied transcription factors and the DNA sequence that is bound by C/EBP
has been well-characterized (122). We have shown previously that GFP-C/EBP
has DNA binding properties similar to that of C/EBP (98). We have also applied
the trapping method to purify B3, which is a developmentally regulated
transcription factor and regulates TFIIIA transcription in early Xenopus oocytes
(99).
In the oligonucleotide trapping method described in this chapter, we have
used the highly specific interaction between complementary strands of DNA to
trap the protein-DNA complex. Similar techniques have been used to purify
mRNA’s from crude mixtures (123) and to make specific DNA affinity columns as
discussed earlier (119). In our method a column attached, single stranded (AC)5
oligonucleotide is used to trap a double stranded footprint region which has a
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(GT)5 tail on both strands from solution. The interaction between a specific
protein and its footprint element is carried out in solution and the protein-DNA
complex is passed over (AC)5 –Sepharose. The latter is able to trap the DNA
protein complex because of highly specific annealing of (AC)5 and its
complement (GT)5 present at the ends of each DNA strand. The protein alone,
can then be eluted by using a buffer containing high salt to weaken the proteinDNA interaction or the intact DNA-protein complex can be eluted by using
moderate temperatures and low salt concentrations to melt the interaction
between (AC)5 and (GT)5. This approach gives lesser contaminants than the
biotin-streptavidin method.
In conventional DNA affinity chromatography the concentration of DNA
that is coupled is very high. It is generally thought that the high DNA
concentrations are necessary for obtaining high yields. Although this is probably
true, having high DNA concentrations has a major disadvantage. Certain
nonspecific proteins, which bind to DNA sequence with low affinity, are able to
bind to the column because of these high DNA concentrations and can
contaminate the protein of interest. We have shown that GFP-C/EBP obtained by
using low concentrations of oligonucleotide and by using our trapping method is
at least three fold purer than that obtained by conventional DNA affinity
chromatography.
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6.2. Methods

6.2.1 Coupling of DNA to Sepharose
EP24 (NH2-GCTGCAGATTGCGCAATCTGCAGC),(AC)5 (NH2ACACACACAC) and E3 (5’-NH2TGTGGTTACTAGGTTACAAATTACCCTAGCAACCATG) were coupled to
CNBr-preactivated Sepharose 4B (Sigma St. Louis, MO USA). Coupling and end
capping were carried out according to the protocol provided by the manufacturer.
“5’ NH2“ in oligonucleotide sequences represents an aminoethyl group added on
the last synthesis cycle with the Aminolink reagent (Applied Biosystems). The E3
column was made double stranded by adding the corresponding complementary
strand αE3 (5’-CATGGTTGCTAGGGTAATTTGTAACCTAGTAACCACA). The
mixture was then heated to 95ºC and allowed to cool slowly to room temperature.
EP24 is self-complementary and does not require the addition of a
complementary strand. The amount of DNA coupled was determined by the
difference in the UV absorption of DNA added and recovered after coupling.
Approximately 20 nmoles of both EP24 and (AC)5 oligonucleotides and 36
nmoles of E3 were coupled per gram of Sepharose.

6.2.2 Production of proteins
GFP-C/EBP was produced by growing Escherichia coli strain BL21
containing plasmid pJ22-GFP-C/EBP as described previously (98).
Xenopus laevis oocyte extract used for B3 purification was made from
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stage I-II Xenopus oocytes as described in (99).

6.2.3 Chromatography
All supports were packed in 1 ml bed volume syringe columns initially
equilibrated in TE0.4 buffer (10 mM Tris, pH 7.5, 1 mM EDTA, 0.4 M NaCl).
Details of elution and the gradient used are given in the figure legends.
For the oligonucleotide trapping method EP24(GT)5
(GCTGCAGATTGCGCAATCTGCAGCGTGTGTGTGT), Bi-EP24 (BiGCTGCAGATTGCGCAATCTGCAGC) where “Bi” represents Biotin introduced
during oligonucleotide synthesis or (GT)5E3/αE3(GT)5 (5’-NH2TGTGGTTACTAGGTTACAAATTACCCTAGCAACCATGTGTGTGTGTG/5’CATGGTTGCTAGGGTAATTTGTAACCTAGTAACCACATGTGTGTGTG) were
incubated with either purified or crude GFP-C/EBP or Xenopus oocyte extract
and passed over the appropriate column. Heparin, salmon sperm DNA (both
obtained from Sigma, St. Louis, MO, USA), T18(TTTTTTTTTTTTTTTTTT), and
µE3
(TGTAACAACTAAACAACAAATTGTTCTAGCTGTTAATGCATTG/ACATTGTTG
ATTTGTTGTTAATCAAGATCCACAATACGTAAC) were used in some
experiments as competitors. The details are given in figure legends. NeutrAvidin
and monomeric avidin-agarose were obtained from Pierce (Rockford IL, USA)
and packed in 1 ml syringe columns.
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6.2.4 Protein assay
Protein concentrations were determined by the Bradford method (124).

6.2.5 Polyacrylamide gel electrophoresis
All the samples were concentrated using Centriplus centrifugal filter
devices supplied by Milipore Corporation (Bedford, USA). One fourth of each
sample was applied to a sodium dodecylsulfate 4-15% polyacrylamide Bio-Rad
precast gradient gel using the method of Laemmli (87) and stained with silver
using the Bio-Rad Laboratory kit (Richmond, CA, USA).

6.2.6 Western blot analysis
Electrophoresis was carried out as above, proteins were then transferred
to nitrocellulose filters as described by Towbin et al. (117). A 1: 5000 dilution of
rabbit polyserum generated against purified B3 (HTI Bioproducts) was used as a
primary antibody for detection of B3. Immunoreactive proteins were visualized by
using 1:3000 diluted rabbit secondary antibody with alkaline phosphatase or
horseradish peroxidase conjugates and stained by using nitroblue tetrazolium or
the electro-chemiluminascence (ECL) method, respectively (61).

6.3. Results
Figure 6.1 is a schematic of the oligonucleotide trapping method. In this
method, a footprint region symbolized as NNNNNN bound specifically by the
protein of interest is extended with a single stranded (GT)5 sequence on each
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Figure 6.1. Schematic of the oligonucleotide trapping method.
The strategy used in the oligonucleotide trapping method is shown
diagrammatically. The circled S represents the chromatographic support, in this
case, Sepharose. First 5’-aminoethyl(AC)5 oligonucleotide is chemically coupled
to Sepharose. A footprint region having a (GT)5 extension on both strands is
incubated with extract containing the protein of interest. This mixture is then
passed over the (AC)5-Sepharose column. The protein alone can then be eluted
by using buffer containing high salt or the DNA protein complex can be eluted
using high temperature.
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strand. For our studies, with GFP-C/EBP we have used EP24 extended with
(GT)5 (EP24(GT)5). EP24 contains the consensus sequence for binding of
C/EBP. This EP24(GT)5 sequence is incubated with extracts containing GFPC/EBP for 30 minutes and then passed over (AC)5-Sepharose. (AC)5- Sepharose
is able to trap the DNA-protein complex because of the specific hybrid formation
between the (GT)5 region of EP24(GT)5 and the (AC)5 region bonded to the
Sepharose. Elution can be achieved using high salt to disrupt the DNA-protein
interaction or by using moderate temperatures and low salt to melt the hybrid
between (AC)5 and (GT)5. When high salt is used GFP-C/EBP alone, free of
DNA, is eluted. When temperature is used, GFP-C/EBP that is still bound to
EP24(GT)5 is eluted. A similar protocol was followed for the purification of B3
from Xenopus oocyte extract except (GT)5E3/αE3(TG)5 was used in the place of
EP24(GT)5.
Two different variants of the oligonucleotide trapping experiment
performed with GFP-C/EBP are shown in Figure 6.2. It can be seen from the
figure that sharp peaks containing GFP-C/EBP are obtained upon elution with
either salt or temperature. The peaks obtained with the two different elution
schemes are similar in peak height and width. GFP-C/EBP alone, in the absence
of EP24(GT)5 was did not bind to (AC)5- Sepharose (data not shown) and hence,
both the peaks observed are due to the specific interaction between GFP-C/EBP
and EP24.
We compared our oligonucleotide trapping method with the biotin
streptavidin method. Figure 6.3 shows the purity of GFP-C/EBP obtained.
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Figure 6.2. Oligonucleotide trapping method for GFP-C/EBP.
20 µl of purified GFP-C/EBP was incubated with 5 nmoles of EP24(GT)5
on ice for 30 min in TE0.4 (10 mM Tris, pH 7.5, 1 mM EDTA, 0.4 M NaCl). This
mixture was then passed over a 1 ml (AC)5-Sepharose column. The column was
washed with 15 ml of TE0.4 at 4°C. The protein was either eluted with TE1.2 (10
mM Tris, pH 7.5, 1 mM EDTA, 1.2 M NaCl) at 4°C for salt elution or with TE (10
mM Tris, pH 7.5, 1 mM EDTA) at 37°C for temperature elution. The flow rate was
maintained at 0.5 ml/min throughout the experiment.

128

Figure 6.3. Comparison of the oligonucleotide trapping method and
avidin-biotin trapping method.
100 µl of a crude bacterial extract containing GFP-C/EBP was mixed with
either BiEP24 (where Bi stands for Biotin group introduced at the 5’ end during
synthesis) or EP24(GT)5 and incubated on ice for 30 min. The mixture containing
BiEP24 was passed over a 500 µl NeutrAvidin column (lane 1) or 500 µl
monomeric avidin column (lanes 2 and 3). The mixture containing EP24(GT)5
was passed over 1 ml (AC)5-Sepharose (lanes 4 and 5). All the columns were
washed with PB0.4 (0.1 M KH2PO4, pH 7.5 and 0.4 M NaCl). The NeutrAvidin
column (lane 1), monomeric avidin column (lane 3) and (AC)5-Sepharose (lane 5)
were eluted with PBS1.2 (0.1 M KH2PO4, pH 7.5 and 1.2 M NaCl). The
monomeric avidin column (lane 2) was eluted with PBS0.4 containing 2 mM
biotin, while (AC)5-Sepharose (lane 4) was eluted with PB (0.1 M KH2PO4, pH 7.5
and 0.1 M NaCl) at 37°C. Lanes 6, 7, 8, 9 and 10 are western blots of proteins in
lane 1, 2, 3, 4 and 5, respectively stained with silver stain.
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Lanes 1, 2 and 3 in Figure 6.3 represent proteins obtained from NeutrAvidin
column with salt elution, monomeric avidin column with biotin elution and
monomeric avidin column with salt elution respectively. NeutrAvidin and
monomeric avidin are genetically modified forms of avidin that are thought to
show minimal nonspecific interactions. Lanes 4 and 5 represent samples
obtained with oligonucleotide trapping method using temperature and salt elution
respectively. The GFP-C/EBP obtained from NeutrAvidin-agarose (lane 1) and
monomeric avidin with biotin elution (lane 2) are significantly purer than that
obtained from the monomeric avidin column with salt elution (lane 3). The
oligonucleotide trapping method with temperature elution (lane 4) yields the
purest GFP-C/EBP. From the silver stained gel it appears that more GFP-C/EBP
is obtained with salt elution in the oligonucleotide trapping method (lane 5) than
with temperature elution. However, western blotting of the same samples (lanes
9 and 10) shows that bands of similar intensities are observed. Hence the larger
size of band for GFP-C/EBP seen in lane 5 is probably because of comigration of
some contaminant protein along with GFP-C/EBP. The same is also true for the
biotin-eluted sample in lane 2.
As discussed before chemical coupling of DNA to Sepharose can cause
modification within the DNA, which could affect efficiency of the column. Our
method on the other hand allows the use of unmodified DNA, which could lead to
higher capacity for proteins. It can be seen from Figure 6.4 that the
oligonucleotide trapping method has higher capacity for GFP-C/EBP and is able
a bind to greater amount of GFP-C/EBP than a conventional DNA affinity column
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Figure 6.4. Capacity of oligonucleotide trapping and DNA affinity
chromatography.
5 nmoles of EP24(GT)5 was mixed with different amounts of purified GFPC/EBP. The mixture was incubated on ice for 30 min and loaded onto a 1 ml
(AC)5-Sepharose column. The column was washed with 10 ml TE0.4 and eluted
with TE1.2. Different amounts of GFP-C/EBP were also loaded onto a 250 µl (5
nmoles DNA) EP24-Sepharose columns, the column was then washed and
eluted as described for the (AC)5-Sepharose column. The fluorescence for GFPC/EBP was monitored continuously by using a Shimadzu fluorescence
spectromonitor RF-530 and the peak areas calculated by using Gilson Unipoint
software. All the columns were run at 4°C and the flow rate for all the column
runs was maintained at 0.5 ml/min.
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having comparable amount of DNA to that used in the trapping experiments. It
can be seen from the figure that the maximum amount of GFP- C/EBP bound in
the trapping experiments is 28,000 fluorescence units, which is equivalent to 0.19
mg of GFP-C/EBP (data not shown). 5 nmoles of EP24 that is used for the
trapping experiment can theoretically bind up to 0.2 mg of GFP-C/EBP assuming
that C/EBP binds to its DNA element as a dimer. Hence around 95% of the
theoretical capacity can be obtained in the oligonucleotide trapping method. The
DNA affinity column also containing 5 nmoles of EP24, can maximally bind only
5,000 fluorescence units of GFP-C/EBP, which corresponds to around 0.03 mg
of GFP-C/EBP, and hence only 15% of the theoretical capacity was achieved in
conventional DNA affinity chromatography.
DNA affinity columns used routinely have a high concentration of DNA
coupled, ranging from 15-200 µM. These high concentrations may be necessary
to obtain high yields. This approach has a major drawback; the high
concentration of DNA on the column can encourage nonspecific binding of
proteins that have a low affinity for DNA. In a crude extract there are typically
many DNA binding proteins and most of these proteins would bind to the DNA on
the column. The lac repressor protein which is the most widely studied
transcription factor has an affinity of Kd = 0.7-11 × 10-5 for nonspecific DNA
sequence (125) and Kd = 3.5 × 10-10-1.7 × 10-12 for a specific operator sequence
(126). Because of this difference in specific and nonspecific affinities of DNA
binding proteins, the specific protein alone would bind with a very high affinity to
the DNA affinity column. However, the high DNA concentration on the column
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drives the binding of even lower affinity binding proteins regardless of the DNA
sequence. Separation of these nonspecific proteins from the protein of interest
with suitable elution scheme would be challenging. This contamination could be
minimized by keeping the concentration of the column DNA low. Although this
could be achieved in conventional DNA affinity columns, it would require low
DNA concentrations in large columns to allow reasonable capacity. The trapping
method can be more efficiently utilized for this purpose.
Figure 6.5 illustrates how the binding equilibria would affect the binding of
contaminant protein having a Kd of 4 × 10-5 M for the DNA footprint used in
conventional DNA affinity chromatography and the oligonucleotide trapping
method. Since the binding constants of C/EBP or B3 for non specific DNA are not
known, we chose to use the constants for lac repressor protein to illustrate the
point. In this model the concentration of DNA in DNA affinity chromatography is
assumed to be 20 µM which is about the average of DNA concentration in most
of our DNA affinity columns. The DNA concentration in the oligonucleotide
trapping method is assumed to be 50 nM as this should be low enough to
discourage binding of nonspecific proteins but sufficient to purify milligrams of the
intended protein. The model also assumes that in either case, the DNA is in
excess and all of the DNA binding proteins in the extract could be bound.
Furthermore, it assumes binding stoichiometry is 1:1 and that equilibrium is
obtained. It can be seen from the figure that conventional DNA affinity column
retains at least three fold more contaminant protein than the oligonucleotide
trapping method though this 3-fold outcome is highly dependant on the
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Figure 6.5. Theoretical model for binding of nonspecific protein in the
oligonucleotide trapping method and DNA affinity chromatography.
Binding of a nonspecific protein having an affinity of 4×10-5 M for the
footprint region in conventional DNA affinity (

) and oligonucleotide trapping ( )

is shown. The concentration of DNA in DNA affinity chromatography and the
oligonucleotide trapping method is assumed to be 20 µM and 50 nM,
respectively. The binding constant of proteins for the small AC10 sequence on
the column is considered to be negligible. The model accounts for each ml of the
crude extract that passes through each column and was constructed in a
Microsoft Excel spreadsheet.
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assumptions made in our model. However, different assumptions also result in
higher purity by trapping method. According to the model both the methods were
able to trap close to 100% of a protein of interest having an affinity of 4 × 10-12 for
the DNA on the column (calculations not shown). The figure shows retention of a
hypothetical contaminant protein as a crude extract passes through columns.
The same fraction of the contaminant protein is retained throughout DNA affinity
chromatograph and accumulates on the column because of its high DNA
concentration. In the trapping method only a negligible fraction of contaminant
protein is retained when the first 50 ml of crude extract passes through the
column because little of the 50 nmole of DNA in the extract has yet bound to the
column, increasing its DNA concentration. The major fraction of the total
contaminant protein retained in the trapping method is retained only when the
last few ml pass through the column, when column DNA concentrations has
reached appreciable amounts. This is because, in the oligonucleotide trapping
method, the initial concentration of the footprint element on the column is very
low and builds up only towards the end. While in the conventional DNA affinity
columns the concentration of DNA footprint remains constant and high through
out.
We tried to apply this model for the actual purification of crude GFPC/EBP. The amount of GFP-C/EBP was adjusted (by adding crude extracts from
non-expressing bacteria) so that it was comparable to the low amounts present in
the cells. The concentration of DNA used in the oligonucleotide trapping method
and DNA affinity chromatography were similar to those in the model experiment.
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It can be seen from Table 6.1 that GFP-C/EBP obtained with the oligonucleotide
trapping method is purer than that obtained with conventional DNA affinity
chromatography. Table 6.1 shows 3-fold higher purity; that is reasonable
considering Figure 6.5. That both the model and the experiment gave 3-fold
improvement is totally fortuitous but the improvement itself confirms the
soundness of the basic model. It can also be seen that the yield obtained with the
oligonucleotide trapping method is comparable to that obtained with DNA affinity
chromatography although almost ten fold more DNA is used in the latter method.
An SDS polyacrylamide gel electrophoresis (PAGE) of the active fractions
fromTable 6.1 is shown in Figure 6.6. It can be seen from the figure that GFPC/EBP obtained (indicated by the arrow) from the oligonucleotide trapping
method is significantly purer than that obtained with conventional DNA affinity
chromatography. Several contaminant protein bands that are present in samples
obtained from DNA affinity chromatography (lane A) are either completely absent
or are highly reduced in samples obtained with oligonucleotide trapping method
(lane T).
Purification of transcription factor B3 was carried out from a Xenopus
oocyte extract by trapping and conventional DNA affinity chromatography. It can
be seen from Figure 6.7 that B3 (indicated by an arrow) obtained with the
trapping method (lane T) is purer than that obtained with DNA affinity
chromatography (lane A) and several contaminant bands present in lane A are
either absent or greatly reduced in B3 obtained from the trapping approach.
Furthermore, in DNA affinity chromatography, B3 on the gel is the upper band of
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Table 6.1. Balance sheet for purification of GFP-C/EBP with DNA
affinity and oligonucleotide trapping method.

Fold Purification

Yield (%)

trapping

3668 +/- 491

36 +/- 16

DNA affinity

1028 +/- 226

24 +/- 2

The results of three experiments were averaged (n=3) and averages are
reported for both the columns. For DNA affinity chromatography 100 µl of purified
GFP-C/EBP was mixed with 10 ml of crude bacterial extract and the volume was
adjusted to 50 ml with TE0.4 and loaded onto 1 ml EP24-Sephorose column. For
the oligonucleotide trapping experiment 2.5 nmoles of EP24(GT)5 was added to
the same extract, incubated on ice for 30 min and then loaded onto (AC)5Sepharose. Both columns were washed with 25 ml of TE0.4 and then eluted with
TE1.2. Active fractions were pooled for assay. The flow rate was maintained at
0.5 ml/min and all the experiments were carried out at 4° C.
The probability (P) that the fold purification obtained by the two methods is
not different is 0.00054. The probability that the yield is not different is 0.146.
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Figure 6.6. Purity of GFP-C/EBP obtained with DNA affinity and the
oligonucleotide trapping method.
The active fractions from the balance sheet in Table 6.1 were
concentrated and equal amounts of GFP-C/EBP were applied to the
polyacrylamide gel and stained with silver. Lanes A and T shows proteins purified
with DNA affinity chromatography and oligonucleotide trapping method,
respectively.
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Figure 6.7. Purification of B3 using the trapping approach.
For DNA affinity chromatography (A) 2.5 ml of Xenopus oocyte extract
was diluted to 50 ml with TE0.4 and loaded onto 1 ml E3-Sepharose column. For
the oligonucleotide trapping experiment (T) 2.5 nmoles of E3TG5/αE3TG5 was
added to the same extract, incubated on ice for 30 min and then loaded onto
AC5-Sepharose. Both columns were washed with 25 ml of TE0.4 and then eluted
with TE1.2. Active fractions were concentrated and applied to SDS
polyacrylamide gel and stained with silver. Lanes A and T shows proteins purified
with DNA affinity chromatography and oligonucleotide trapping method,
respectively. The flow rate was maintained at 0.5 ml/min and all the experiments
were carried out at 4° C.
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closely spaced doublet which would be difficult to remove. This contaminant is
not retained by trapping.
While Figure 6.7 shows that trapping can be successfully used for
obtaining high purity B3 Figure 6.8 shows that trapping approach can be further
improved by using different competitors. It can be seen from the figure that
heparin alone (lanes 2 and 7) and heparin along with T18 (lanes 3 and 8) could
be successfully used for improving purity of B3 and the latter approach gives
highly purified B3 as seen in lane 3. Specific competitor µE3 (lanes 4 and 9) and
salmon sperm DNA (lanes 5 and 10) could not be used as competitors because
they greatly affect the yield of B3 as can be seen in the western blot in lanes 9
and 10.
High purity B3 was also obtained with the Bi-column method (Figure 5.6).
The major drawback of the bi-column method is the lower yields obtained. The
Bi-column method could be scaled up to obtain higher amounts of B3 but this
would involve synthesis of at least 10 ml resins of two different DNA affinity
columns. Trapping on the other hand is easier to scale up. It can be seen from
Figure 6.9 that highly pure B3 can be obtained (lane 2) after scaling up the
trapping method used in Figure 6.8 by 10 fold. Around 5 µg B3 (data not shown)
was obtained by this approach starting from 2 ml of crude oocyte extract and
could be easily stained with Coomassie blue staining Figure 6.9.
Figure 6.10 shows that the B3 obtained with the trapping method is active.
It can be seen from the figure that as little as 1µl of purified protein is able to shift
the mobility of E3 oligonucleotide in the presence of specific competitor. 15 µl of
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Figure 6.8. Purification of B3 using the trapping approach in the presence
of different competitors.
200 µl of Xenopus oocyte extract was diluted to 4 ml using TE0.4 and
incubated with 0.5µM of E3TG5/αE3TG5 along with competitors 4 mg/ml heparin
(lanes 2 and 7), 4 mg/ml heparin and 20µM of T18 (lanes 3 and 8), 5µM µE3 and
20µM T18 (lanes 4 and 9), and 1 mg/ml salmon sperm DNA (lanes 5 and 10).
The mixtures were incubated on ice for 30 min and then loaded onto AC5Sepharose. Columns were washed with 25 ml of TE0.4 and then eluted with
TE1.2. Active fractions were concentrated and run on a SDS 4-15 %
polyacrylamide gel (lanes 1-5) and stained with silver, or subjected to western
blotting (lanes 6-10) developed with NBT. Lanes 1 and 6 show 2µl crude extract.
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Figure 6.9. Large scale purification of B3 using the trapping approach.
2 ml of Xenopus oocyte extract was diluted to 40 ml using TE0.4 and
incubated with 0.5µM of E3TG5/αE3TG5 along with competitors 4 mg/ml heparin
and 20µM of T18. The mixtures were incubated on ice for 30 min and then loaded
onto a 5 ml AC5-Sepharose. The column was washed with 40 ml of TE0.4 and
then eluted with TE1.2. Active fractions were concentrated and applied to SDS
polyacrylamide gel and stained with Coomassie blue lane 2 and 2. Or subjected
to western blotting lane 4. Lanes 1 and 3 show 2µl crude.
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Figure 6.10. Gel mobility shift assay of the purified B3.
Gel mobility shift was carried as described in (99) 20 picomoles of labeled
E3TG5/αE3TG5 was incubated with different amounts (in µl and indicated top on
of the well) of purified B3 in presence of the specific competitor. The reaction was
resolved on a nondenaturing PAGE as described by Pfaff et al. (99).
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purified B3 completely saturated 20 picomoles moles of E3 oligonucleotide used
in the reaction.

6.4. Discussion
Coupling of DNA to solid supports in conventional DNA affinity
chromatography has allowed purification of many transcription factors. But this
technique suffers from two major drawbacks. As already discussed, coupling can
lead to modification in the DNA sequence unless special coupling procedures are
used. Base modification can affect the interaction with the protein of interest.
Methods such as enzymatic synthesis or biotin avidin technologies can solve this
problem to a certain extent but each of these methods has its own limitations.
From Figure 6.2 it can be seen that a purer protein can be obtained with our
oligonucleotide trapping method than the biotin-streptavidin method, even after
using modified forms of streptavidin such as NeutrAvidin and monomeric avidin
which have lower nonspecific interactions with proteins. A method similar to our
method in which a footprint extended with polyA is used, has also been
described (119). In that method, salt elution was used to obtain the protein and
from our results it is clear that elution with high temperature is a better approach
than salt elution in terms of purity of GFP-C/EBP obtained.
The second drawback of DNA affinity chromatography is that the DNA
immobilized on the column is not in true solution and hence, the kinetic
parameters of binding of proteins to DNA cannot be extrapolated to column
chromatography. Methods such as magnetic bead purification and the previously
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described polyA trapping method (119) could have been efficiently used to solve
this problem, but most of the methods described so far fail to do so and employ
biotin group or oligonucleotide extensions as other means of coupling a footprint
region to a solid support and then perform conventional affinity chromatography.
In other cases when the binding is carried out in solution the concentration of
DNA used is very high. Such high concentration can encourage binding of
nonspecific proteins.
In our method the binding between protein and DNA occurs in solution
and only then is an (AC)5 –Sepharose used to trap the DNA-protein complex. By
carrying out the reaction in solution we can adjust the concentrations of DNA to
levels which do not favor the binding of nonspecific proteins. This can be very
rarely achieved by conventional column chromatography. The advantage of
using low concentrations of DNA are clear from Table 6.1 and Figure 6.6 which
show that GFP-C/EBP obtained from our approach is significantly purer than that
obtained with conventional chromatography. It is important to note that we have
used high salt to elute GFP-C/EBP in the oligonucleotide trapping method in
Table 6.1 and Figure 6.6. High salt is not the best method for elution and better
purity can be obtained with temperature elution (Figure 6.3). However since
accurate measurements of fluorescence are required for the balance sheet in
Table 6.1 and the DNA that is bound to protein after temperature elution can
affect its fluorescence, salt elution was chosen.
Several competitors such as heparin, specific DNA (µE3), nonspecific
DNA (salmon sperm DNA), and single stranded DNA (T18) could be used
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together with the trapping approach. It is noteworthy that the use of single
stranded DNA along with heparin was the most efficient in purifying B3. T18
probably competes with AC5 for binding to single strand binding proteins and
hence prevents contamination by these proteins.
From the overall results it can be seen that our oligonucleotide trapping
method is a better alternative to conventional DNA affinity chromatography. The
oligonucleotide trapping method can be further enhanced by using competitors to
obtain highly purified DNA binding proteins.

147

Chapter: 7. Conclusions
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Sequence specific DNA affinity chromatography has the highest selectivity
and is the most powerful chromatographic technique known for the purification of
transcription factors and other DNA binding proteins. As seen from Table 1.1
DNA affinity chromatography has been widely used for the purification of
transcription factors. Pioneering work such as coupling of DNA to silica, the
enzymatic synthesis of DNA affinity columns, and the use of competitor DNA has
led to significant advances in the technique. However, despite of these efforts
DNA affinity chromatography alone has rarely yielded homogenous protein. This
is mainly because the technique in its original form had a restricted number of
available elution strategies and other aspects, such as the appropriate length and
concentration of DNA used for making the affinity columns, were also not fully
characterized. Hence the main focus of our study was to optimize DNA affinity
chromatography by developing new elution strategies and by defining the nature
of DNA used for making sequence specific columns and to apply the knowledge
obtained to develop new affinity methods for the purification of transcription
factors.
We have shown that concatemeric DNA affinity columns suffer from low
resolution, which affects the purity of proteins obtained (Chapter 3). Moreover the
most efficient way to increase the complexity of DNA sequence used for coupling
is to include homopolymeric sequences such as polydA:polydT at either 5’ or 3’
end of the footprint region (Chapters 2 and 3).
Heparin elution was developed as an alternative to salt elution (Chapter
4). In our experiments with lac repressor protein we got higher purity with heparin

149

elution than with salt elution. Other DNA binding proteins when eluted with
heparin may or may not have higher purity than salt elution. Heparin elution
offers a new variation in DNA affinity chromatography and allows repeated use of
DNA affinity chromatography with different elution strategies. This is epitomized
in the Bi-column method, which involves the use of two sequential sequence
specific columns with different specificity and two different elution strategies, viz.
Salt and heparin elution. This method was based on our prior knowledge that
DNA affinity columns containing an untailed footprint region show shorter
retention times than columns containing more complex, tailed footprints
(Chapters 2 and 3). This method was successfully used for purification of three
different transcription factors (Chapter 5) to near homogeneity in a single
operation.
Conventional DNA affinity columns contain high concentration of DNA
which can lead to retention of nonspecific proteins. Using lower concentration of
DNA in should lead to increased purity but would be expected to adversely affect
the yield. The oligonucleotide trapping method was developed to allow
purification of milligram quantities of protein by using a tailed footprint region at
concentration low enough to discourage binding of nonspecific proteins. By
binding protein to DNA in solution, yield does not suffer table 6.1) and capacity is
actually improved (Figure 6.4). This method was successfully used to obtain
highly pure B3 in quantities high enough to allow further analysis.
This work has improved our understanding of DNA affinity
chromatography and has led to development of new methods for the purification
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of transcription factors. Some of the highlights of this work have been single step
purification of B3 and up to 3000 fold purification of recombinant C/EBP which is
the highest fold purification obtained using DNA affinity chromatography in our
lab. The methods developed could also be used for the purification of other DNA
binding proteins with only slight modifications and whether or not this work finds
future application remains to be seen.
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